Transcriptional	O
regulation	O
during	O
T-cell	B-cell_type
development	O
:	O
the	O
alpha	B-DNA
TCR	I-DNA
gene	I-DNA
as	O
a	O
molecular	O
model	O
.	O

The	O
regulation	O
of	O
gene	O
expression	O
during	O
lymphocyte	B-cell_type
differentiation	O
is	O
a	O
complex	O
process	O
involving	O
interactions	O
between	O
multiple	B-DNA
positive	I-DNA
and	I-DNA
negative	I-DNA
transcriptional	I-DNA
regulatory	I-DNA
elements	I-DNA
.	O

In	O
this	O
article	O
,	O
transcriptional	O
regulation	O
of	O
the	O
archetypal	B-DNA
T-cell-specific	I-DNA
gene	I-DNA
,	O
alpha	B-DNA
TCR	I-DNA
,	O
is	O
discussed	O
.	O

Major	O
recent	O
developments	O
,	O
including	O
the	O
identification	O
of	O
novel	O
families	O
of	O
transcription	B-DNA
factors	I-DNA
that	O
regulate	O
multiple	O
T-cell	B-DNA
genes	I-DNA
during	O
thymocyte	O
ontogeny	O
and	O
T-cell	B-cell_type
activation	O
,	O
are	O
described	O
.	O

REVIEW	NULL
Transcriptional	NULL
regulation	NULL
in	NULL
lymphocytes	NULL
Understanding	NULL
the	NULL
mechanisms	NULL
that	NULL
regulate	NULL
the	NULL
development	NULL
of	NULL
complex	NULL
mammalian	NULL
organisms	NULL
is	NULL
one	NULL
of	NULL
the	NULL
most	NULL
fascinating	NULL
problems	NULL
in	NULL
biology	NULL
.	NULL

The	NULL
coordinated	NULL
transcriptional	NULL
regulation	NULL
of	NULL
specific	NULL
sets	NULL
of	NULL
genes	NULL
defines	NULL
the	NULL
framework	NULL
upon	NULL
which	NULL
cell	NULL
determination	NULL
and	NULL
differentiation	NULL
are	NULL
established	NULL
.	NULL

Thus	NULL
,	NULL
an	NULL
understanding	NULL
of	NULL
tissue-specific	NULL
gene	NULL
transcription	NULL
will	NULL
significantly	NULL
advance	NULL
our	NULL
knowledge	NULL
of	NULL
mammalian	NULL
development	NULL
.	NULL

Lymphoid	NULL
differentiation	NULL
,	NULL
the	NULL
process	NULL
by	NULL
which	NULL
committed	NULL
progenitor	NULL
cells	NULL
give	NULL
rise	NULL
to	NULL
both	NULL
the	NULL
T-	NULL
and	NULL
B-cell	NULL
lineages	NULL
,	NULL
has	NULL
long	NULL
been	NULL
used	NULL
as	NULL
a	NULL
paradigm	NULL
for	NULL
studies	NULL
of	NULL
both	NULL
tissue-specific	NULL
and	NULL
developmentally	NULL
regulated	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
following	NULL
two	NULL
papers	NULL
review	NULL
different	NULL
aspects	NULL
of	NULL
transcriptional	NULL
control	NULL
during	NULL
T-	NULL
and	NULL
B-cell	NULL
development	NULL
,	NULL
focusing	NULL
on	NULL
two	NULL
of	NULL
the	NULL
best-understood	NULL
systems	NULL
,	NULL
namely	NULL
the	NULL
«	NULL
TCR	NULL
gene	NULL
and	NULL
the	NULL
immunoglobu-lin	NULL
genes	NULL
.	NULL

Both	NULL
conclude	NULL
that	NULL
lymphocyte-specific	NULL
gene	NULL
expression	NULL
is	NULL
controlled	NULL
by	NULL
complex	NULL
regulatory	NULL
circuits	NULL
involving	NULL
interactions	NULL
among	NULL
multiple	NULL
families	NULL
of	NULL
ubiquitous	NULL
and	NULL
lineage-specific	NULL
transcription	NULL
factors	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
during	NULL
T-cell	NULL
development	NULL
:	NULL
the	NULL
a	NULL
TCR	NULL
gene	NULL
as	NULL
a	NULL
molecular	NULL
model	NULL
Jeffrey	NULL
M.	NULL
Leiden	NULL
The	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
during	NULL
lymphocyte	NULL
differentiation	NULL
is	NULL
a	NULL
complex	NULL
process	NULL
involving	NULL
interactions	NULL
between	NULL
multiple	NULL
positive	NULL
and	NULL
negative	NULL
transcriptional	NULL
regulatory	NULL
elements	NULL
.	NULL

In	NULL
this	NULL
article	NULL
,	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
archetypal	NULL
T-cell-specific	NULL
gene	NULL
,	NULL
a	NULL
TCR	NULL
,	NULL
is	NULL
discussed	NULL
.	NULL

Major	NULL
recent	NULL
develop-ments	NULL
,	NULL
including	NULL
the	NULL
identification	NULL
of	NULL
novel	NULL
families	NULL
of	NULL
transcription	NULL
factors	NULL
that	NULL
regulate	NULL
multiple	NULL
T-cell	NULL
genes	NULL
during	NULL
thymocyte	NULL
ontogeny	NULL
and	NULL
T-cell	NULL
activation	NULL
,	NULL
are	NULL
described	NULL
.	NULL

The	NULL
differentiation	NULL
of	NULL
mature	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
from	NULL
committed	NULL
lymphoid	NULL
progenitors	NULL
is	NULL
an	NULL
excellent	NULL
model	NULL
system	NULL
for	NULL
understanding	NULL
transcriptional	NULL
regulation	NULL
during	NULL
mammalian	NULL
development	NULL
'	NULL
``	NULL
.	NULL

Studies	NULL
of	NULL
murine	NULL
and	NULL
human	NULL
lymphopoiesis	NULL
have	NULL
allowed	NULL
the	NULL
identification	NULL
of	NULL
sets	NULL
of	NULL
tissue-specific	NULL
genes	NULL
that	NULL
are	NULL
transcriptionally	NULL
regulated	NULL
at	NULL
distinct	NULL
developmental	NULL
time	NULL
points'*	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
tumor	NULL
cell	NULL
lines	NULL
,	NULL
representing	NULL
specific	NULL
stages	NULL
of	NULL
B-	NULL
and	NULL
T-cell	NULL
development	NULL
,	NULL
have	NULL
been	NULL
characterized	NULL
and	NULL
grown	NULL
in	NULL
vitro	NULL
.	NULL

Some	NULL
of	NULL
these	NULL
cell	NULL
lines	NULL
can	NULL
be	NULL
stimulated	NULL
to	NULL
differentiate	NULL
in	NULL
vitro	NULL
by	NULL
the	NULL
appropriate	NULL
extracellular	NULL
signals	NULL
.	NULL

The	NULL
a	NULL
TCR	NULL
gene	NULL
has	NULL
been	NULL
studied	NULL
as	NULL
a	NULL
paradigm	NULL
of	NULL
lineage-specific	NULL
and	NULL
developmentally	NULL
regulated	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
a	NULL
TCR	NULL
gene	NULL
rearrangement	NULL
and	NULL
expression	NULL
are	NULL
restricted	NULL
to	NULL
aB	NULL
TCR	NULL
T	NULL
cells*~	NULL
``	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
this	NULL
gene	NULL
is	NULL
developmentally	NULL
regulated	NULL
in	NULL
thymocytes	NULL
:	NULL
«	NULL
TCR	NULL
gene	NULL
expression	NULL
is	NULL
first	NULL
detected	NULL
on	NULL
fetal	NULL
day	NULL
17	NULL
in	NULL
mouse	NULL
thymocytes	NULL
,	NULL
several	NULL
days	NULL
after	NULL
8	NULL
,	NULL
B	NULL
and	NULL
y	NULL
TCR	NULL
gene	NULL
expression	NULL
``	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
a	NULL
TCR	NULL
gene	NULL
is	NULL
specifically	NULL
upregulated	NULL
during	NULL
the	NULL
transition	NULL
from	NULL
immature	NULL
CD34	NULL
``	NULL
cortical	NULL
thymocytes	NULL
to	NULL
the	NULL
more	NULL
mature	NULL
cells	NULL
found	NULL
in	NULL
the	NULL
thymic	NULL
medulla	NULL
and	NULL
the	NULL
peripheral	NULL
lymphoid	NULL
system	NULL
.	NULL

This	NULL
review	NULL
summarizes	NULL
the	NULL
current	NULL
state	NULL
of	NULL
knowledge	NULL
concerning	NULL
the	NULL
molecular	NULL
mechanisms	NULL
that	NULL
regulate	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
a	NULL
TCR	NULL
gene	NULL
,	NULL
with	NULL
particular	NULL
emphasis	NULL
on	NULL
several	NULL
recently	NULL
cloned	NULL
lymphoid-specific	NULL
transcription	NULL
factors	NULL
that	NULL
modulate	NULL
«	NULL
TCR	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
structure	NULL
of	NULL
the	NULL
«	NULL
TCR	NULL
enhancer	NULL
is	NULL
compared	NULL
with	NULL
those	NULL
©	NULL
1992	NULL
,	NULL
Elsevier	NULL
Science	NULL
Publishers	NULL
Ltd	NULL
,	NULL
UK	NULL
.	NULL

Immunology	NULL
Today	NULL
22	NULL
Vol	NULL
.	NULL

13	NULL
No	NULL
.	NULL

1	NULL
1992	NULL
REVIEW	NULL
of	NULL
other	NULL
recently	NULL
identified	NULL
T-cell-specific	NULL
transcriptional	NULL
regulatory	NULL
elements	NULL
.	NULL

This	NULL
comparison	NULL
suggests	NULL
that	NULL
the	NULL
same	NULL
transcription	NULL
factors	NULL
that	NULL
control	NULL
«	NULL
TCR	NULL
gene	NULL
expression	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
multiple	NULL
T-cell	NULL
genes	NULL
during	NULL
both	NULL
development	NULL
and	NULL
activation	NULL
.	NULL

Identification	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
«	NULL
TCR	NULL
transcriptional	NULL
enhancer	NULL
As	NULL
first	NULL
demonstrated	NULL
by	NULL
Davis	NULL
and	NULL
co-workers	NULL
'	NULL
``	NULL
,	NULL
the	NULL
a	NULL
and	NULL
8	NULL
TCR	NULL
genes	NULL
are	NULL
tightly	NULL
linked	NULL
in	NULL
humans	NULL
and	NULL
mice	NULL
;	NULL
the	NULL
8	NULL
TCR	NULL
gene	NULL
lies	NULL
embedded	NULL
within	NULL
the	NULL
«	NULL
TCR	NULL
locus	NULL
between	NULL
V	NULL
,	NULL
,	NULL
and	NULL
J	NULL
,	NULL
,	NULL
,	NULL
such	NULL
that	NULL
rearrangements	NULL
of	NULL
the	NULL
«	NULL
TCR	NULL
gene	NULL
result	NULL
in	NULL
the	NULL
deletion	NULL
of	NULL
the	NULL
entire	NULL
8	NULL
TCR	NULL
locus	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Despite	NULL
this	NULL
tight	NULL
linkage	NULL
,	NULL
the	NULL
rearrangement	NULL
and	NULL
expression	NULL
of	NULL
these	NULL
two	NULL
genes	NULL
is	NULL
lineage	NULL
specific	NULL
,	NULL
that	NULL
is	NULL
the	NULL
«	NULL
TCR	NULL
gene	NULL
is	NULL
expressed	NULL
almost	NULL
exclusively	NULL
in	NULL
«	NULL
B	NULL
TCR	NULL
cells	NULL
,	NULL
whereas	NULL
8	NULL
TCR	NULL
gene	NULL
rearrangement	NULL
and	NULL
expression	NULL
is	NULL
limited	NULL
to	NULL
cells	NULL
of	NULL
the	NULL
y8	NULL
Thus	NULL
,	NULL
the	NULL
«	NULL
TCR	NULL
gene	NULL
represents	NULL
an	NULL
excellent	NULL
model	NULL
system	NULL
for	NULL
studies	NULL
of	NULL
lineage-specific	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Initial	NULL
studies	NULL
of	NULL
several	NULL
TCR	NULL
V	NULL
,	NULL
,	NULL
promoters	NULL
demonstrated	NULL
that	NULL
these	NULL
promoters	NULL
lack	NULL
significant	NULL
transcriptional	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
``	NULL
.	NULL

This	NULL
suggested	NULL
the	NULL
existence	NULL
of	NULL
intragenic	NULL
transcriptional	NULL
regulatory	NULL
sequences	NULL
that	NULL
control	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
«	NULL
TCR	NULL
gene	NULL
.	NULL

Potent	NULL
T-cell-specific	NULL
transcriptional	NULL
enhancers	NULL
were	NULL
subsequently	NULL
identified	NULL
3	NULL
'	NULL
to	NULL
both	NULL
the	NULL
mouse	NULL
and	NULL
human	NULL
a	NULL
TCR	NULL
genes	NULL
(	NULL
Fig	NULL
.	NULL

|	NULL
and	NULL
Refs	NULL
12,13	NULL
)	NULL
.	NULL

These	NULL
enhancers	NULL
,	NULL
which	NULL
display	NULL
greater	NULL
than	NULL
90	NULL
%	NULL
sequence	NULL
identity	NULL
,	NULL
are	NULL
both	NULL
located	NULL
3-4.5	NULL
kilobases	NULL
(	NULL
kb	NULL
)	NULL
3	NULL
``	NULL
of	NULL
the	NULL
single	NULL
C	NULL
,	NULL
,	NULL
gene	NULL
segment	NULL
.	NULL

Because	NULL
the	NULL
5'-most	NULL
J	NULL
,	NULL
,	NULL
gene	NULL
segment	NULL
is	NULL
located	NULL
as	NULL
much	NULL
as	NULL
75	NULL
kb	NULL
5	NULL
to	NULL
C.	NULL
,	NULL
**	NULL
,	NULL
these	NULL
enhancers	NULL
must	NULL
be	NULL
able	NULL
to	NULL
act	NULL
over	NULL
long	NULL
distances	NULL
.	NULL

Further	NULL
studies	NULL
of	NULL
the	NULL
human	NULL
a	NULL
TCR	NULL
enhancer	NULL
localized	NULL
its	NULL
activity	NULL
to	NULL
a	NULL
275	NULL
bp	NULL
fragment	NULL
that	NULL
was	NULL
preferentially	NULL
active	NULL
in	NULL
«	NULL
B	NULL
TCR	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
which	NULL
was	NULL
required	NULL
for	NULL
high-level	NULL
transcription	NULL
from	NULL
a	NULL
TCR	NULL
V	NULL
,	NULL
,	NULL
promoter	NULL
.	NULL

This	NULL
enhancer	NULL
also	NULL
stimulated	NULL
high-level	NULL
T-cell-specific	NULL
transcription	NULL
from	NULL
heterologous	NULL
promoters	NULL
such	NULL
as	NULL
the	NULL
minimal	NULL
SV40	NULL
or	NULL
c-fos	NULL
promoters	NULL
``	NULL
.	NULL

DNase	NULL
!	NULL

footprint	NULL
analyses	NULL
of	NULL
the	NULL
human	NULL
a	NULL
TCR	NULL
enhancer	NULL
allowed	NULL
the	NULL
identification	NULL
of	NULL
four	NULL
functionally	NULL
significant	NULL
nuclear	NULL
protein-binding	NULL
sites	NULL
,	NULL
called	NULL
Ta	NULL
1-Ta4	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
Ref	NULL
.	NULL

12	NULL
)	NULL
.	NULL

Given	NULL
the	NULL
pattern	NULL
of	NULL
DNasel	NULL
footprinting	NULL
,	NULL
it	NULL
was	NULL
suggested	NULL
that	NULL
Ta2	NULL
might	NULL
be	NULL
composed	NULL
of	NULL
two	NULL
distinct	NULL
nuclear	NULL
protein-binding	NULL
sites	NULL
.	NULL

A	NULL
similar	NULL
analysis	NULL
of	NULL
the	NULL
mouse	NULL
enhancer	NULL
identified	NULL
nuclear	NULL
protein-binding	NULL
sites	NULL
corresponding	NULL
to	NULL
Ta	NULL
1	NULL
(	NULL
NFa2	NULL
)	NULL
and	NULL
Ta2	NULL
(	NULL
NFa3	NULL
and	NULL
NFa4	NULL
)	NULL
.	NULL

The	NULL
Ta3	NULL
and	NULL
Ta4	NULL
sites	NULL
were	NULL
not	NULL
detected	NULL
in	NULL
the	NULL
analysis	NULL
of	NULL
the	NULL
mouse	NULL
enhancer	NULL
because	NULL
the	NULL
fragment	NULL
used	NULL
for	NULL
footprinting	NULL
did	NULL
not	NULL
extend	NULL
3	NULL
'	NULL
of	NULL
Ta2	NULL
.	NULL

Extensive	NULL
mutational	NULL
and	NULL
deletional	NULL
analyses	NULL
of	NULL
the	NULL
human	NULL
a	NULL
TCR	NULL
enhancer	NULL
demonstrated	NULL
that	NULL
,	NULL
at	NULL
least	NULL
in	NULL
the	NULL
Jurkat	NULL
T-cell	NULL
line	NULL
,	NULL
the	NULL
minimal	NULL
«	NULL
TCR	NULL
enhancer	NULL
is	NULL
contained	NULL
within	NULL
a	NULL
116	NULL
bp	NULL
fragment	NULL
containing	NULL
only	NULL
the	NULL
Tal	NULL
and	NULL
Ta	NULL
?	NULL

nuclear	NULL
protein-binding	NULL
sites	NULL
``	NULL
!	NULL

.	NULL

A	NULL
fragment	NULL
containing	NULL
the	NULL
Ta3	NULL
and	NULL
Ta4	NULL
elements	NULL
alone	NULL
displayed	NULL
low-level	NULL
enhancer	NULL
activity	NULL
(	NULL
6-10-fold	NULL
compared	NULL
with	NULL
50-100-fold	NULL
for	NULL
the	NULL
Tal-	NULL
and	NULL
Ta2-containing	NULL
fragment	NULL
)	NULL
.	NULL

Both	NULL
Tal	NULL
and	NULL
Ta2	NULL
were	NULL
required	NULL
for	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
minimal	NULL
a	NULL
TCR	NULL
enhancer	NULL
because	NULL
mutation	NULL
and/or	NULL
deletion	NULL
of	NULL
either	NULL
site	NULL
abolished	NULL
transcriptional	NULL
regulatory	NULL
activity	NULL
``	NULL
``	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
spacing	NULL
between	NULL
Tal	NULL
and	NULL
Ta2	NULL
was	NULL
critical	NULL
for	NULL
enhancer	NULL
function	NULL
;	NULL
TEA	NULL
¥J	NULL
,	NULL
«	NULL
Enh	NULL
J.	NULL
,	NULL
c.	NULL
|	NULL
rec	NULL
JG	NULL
Cb	NULL
vv	NULL
,	NULL
_	NULL
lb	NULL
A	NULL
lvil/	NULL
«	NULL
6	NULL
TCR	NULL
*	NULL
4.5	NULL
kb	NULL
3	NULL
'	NULL
of	NULL
C	NULL
,	NULL
e	NULL
275	NULL
bp	NULL
*	NULL
More	NULL
than	NULL
90	NULL
%	NULL
conserved	NULL
between	NULL
mouse	NULL
and	NULL
human	NULL
*	NULL
Required	NULL
for	NULL
high	NULL
level	NULL
«	NULL
a	NULL
TCR	NULL
expression	NULL
*	NULL
T-cell-specific	NULL
*	NULL
Four	NULL
nuclear	NULL
protein-binding	NULL
sites	NULL
(	NULL
Ta1i-Ta4	NULL
)	NULL
*	NULL
PMA-inducible	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

A	NULL
schematic	NULL
representation	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
receptor	NULL
ad	NULL
locus	NULL
.	NULL

The	NULL
general	NULL
organization	NULL
of	NULL
the	NULL
locus	NULL
and	NULL
the	NULL
location	NULL
of	NULL
8	NULL
,	NULL
,	NULL
.	NULL

,	NULL
TEA	NULL
and	NULL
¥	NULL
J	NULL
,	NULL
,	NULL
are	NULL
from	NULL
Hockett	NULL
et	NULL
al	NULL
.	NULL
``	NULL

Variable	NULL
(	NULL
V	NULL
)	NULL
,	NULL
diversity	NULL
(	NULL
D	NULL
)	NULL
,	NULL
joining	NULL
(	NULL
J	NULL
)	NULL
and	NULL
constant	NULL
(	NULL
C	NULL
)	NULL
gene	NULL
segments	NULL
are	NULL
shown	NULL
as	NULL
boxes	NULL
.	NULL

The	NULL
T-cell	NULL
receptor	NULL
a	NULL
enhancer	NULL
(	NULL
aknh	NULL
)	NULL
is	NULL
shown	NULL
as	NULL
a	NULL
cross-hatched	NULL
box	NULL
.	NULL

The	NULL
precise	NULL
number	NULL
and	NULL
organization	NULL
of	NULL
V.	NULL
,	NULL
,	NULL
V	NULL
,	NULL
and	NULL
J	NULL
,	NULL
,	NULL
gene	NULL
segments	NULL
are	NULL
unknown	NULL
.	NULL

kb	NULL
:	NULL
kilobase	NULL
pairs	NULL
;	NULL
bp	NULL
:	NULL
base	NULL
pairs	NULL
;	NULL
PMA	NULL
:	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
.	NULL

reducing	NULL
the	NULL
normal	NULL
20	NULL
bp	NULL
spacing	NULL
to	NULL
15	NULL
bp	NULL
eliminated	NULL
enhancer	NULL
activity	NULL
,	NULL
as	NULL
did	NULL
increasing	NULL
the	NULL
spacing	NULL
to	NULL
more	NULL
than	NULL
85	NULL
bp	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
phasing	NULL
of	NULL
the	NULL
Tal	NULL
and	NULL
Ta2	NULL
elements	NULL
on	NULL
the	NULL
DNA	NULL
helix	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
critical	NULL
;	NULL
increasing	NULL
the	NULL
spacing	NULL
from	NULL
20	NULL
to	NULL
25	NULL
bp	NULL
had	NULL
a	NULL
relatively	NULL
small	NULL
effect	NULL
on	NULL
enhancer	NULL
activity	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
Ta3	NULL
and	NULL
Ta4	NULL
elements	NULL
,	NULL
while	NULL
themselves	NULL
not	NULL
possessing	NULL
high-level	NULL
enhancer	NULL
activity	NULL
,	NULL
could	NULL
compensate	NULL
for	NULL
mutations	NULL
in	NULL
Tal	NULL
or	NULL
Ta	NULL
«	NULL
2	NULL
that	NULL
abolished	NULL
enhancer	NULL
activity	NULL
``	NULL
``	NULL
.	NULL

Thus	NULL
,	NULL
Ta3	NULL
and	NULL
Ta4	NULL
represent	NULL
redundant	NULL
elements	NULL
,	NULL
at	NULL
least	NULL
as	NULL
assayed	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

It	NULL
should	NULL
be	NULL
emphasized	NULL
,	NULL
however	NULL
,	NULL
that	NULL
these	NULL
results	NULL
did	NULL
not	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
Ta3	NULL
and/or	NULL
Ta4	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
modulating	NULL
«	NULL
TCR	NULL
enhancer	NULL
function	NULL
at	NULL
some	NULL
earlier	NULL
stage	NULL
in	NULL
T-cell	NULL
development	NULL
,	NULL
or	NULL
in	NULL
response	NULL
to	NULL
specific	NULL
extracellular	NULL
signals	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
functional	NULL
analyses	NULL
revealed	NULL
that	NULL
the	NULL
«	NULL
TCR	NULL
enhancer	NULL
is	NULL
composed	NULL
of	NULL
multiple	NULL
,	NULL
partially	NULL
redundant	NULL
,	NULL
nuclear	NULL
protein-binding	NULL
sites	NULL
.	NULL

Interactions	NULL
between	NULL
proteins	NULL
binding	NULL
to	NULL
these	NULL
different	NULL
sites	NULL
appear	NULL
to	NULL
be	NULL
important	NULL
for	NULL
enhancer	NULL
function	NULL
.	NULL

Transcription	NULL
factors	NULL
that	NULL
regulate	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
TCR	NULL
enhancer	NULL
An	NULL
examination	NULL
of	NULL
the	NULL
sequences	NULL
of	NULL
the	NULL
nuclear	NULL
protein-binding	NULL
sites	NULL
of	NULL
the	NULL
mouse	NULL
and	NULL
human	NULL
a	NULL
TCR	NULL
enhancers	NULL
revealed	NULL
several	NULL
previously	NULL
described	NULL
transcriptional	NULL
regulatory	NULL
elements	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
Tal	NULL
contains	NULL
an	NULL
evolutionarily-conserved	NULL
cAMP	NULL
response	NULL
element	NULL
(	NULL
TGACGTCA	NULL
)	NULL
``	NULL
.	NULL

Similarly	NULL
,	NULL
Ta3	NULL
contains	NULL
overlapping	NULL
AP:2	NULL
(	NULL
CCCCAGGC	NULL
)	NULL
-like'*	NULL
``	NULL
``	NULL
and	NULL
KE2	NULL
(	NULL
E	NULL
box	NULL
)	NULL
(	NULL
AGGCCACGTGCCGA	NULL
)	NULL
-like'*	NULL
motifs	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
T2	NULL
and	NULL
Ta4	NULL
do	NULL
not	NULL
contain	NULL
previously	NULL
identified	NULL
nuclear	NULL
protein-binding	NULL
sites	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
,	NULL
using	NULL
synthetic	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
Tal-Ta4	NULL
,	NULL
demonstrated	NULL
that	NULL
Tal	NULL
binds	NULL
a	NULL
set	NULL
of	NULL
four	NULL
to	NULL
six	NULL
ubiquitously	NULL
expressed	NULL
cAMP	NULL
response	NULL
element	NULL
binding	NULL
(	NULL
CREB	NULL
)	NULL
proteins	NULL
``	NULL
*	NULL
'	NULL
``	NULL
.	NULL

Binding	NULL
of	NULL
each	NULL
of	NULL
these	NULL
proteins	NULL
was	NULL
inhibited	NULL
by	NULL
mutations	NULL
Immunology	NULL
Today	NULL
23	NULL
Vol	NULL
.	NULL

13	NULL
No	NULL
.	NULL

I	NULL
1992	NULL
REVIEW	NULL
e	NULL
``	NULL
»	NULL
a	NULL
~*	NULL
TCF-1/LEF-1	NULL
CRE	NULL
GATA	NULL
AP	NULL
-2	NULL
CTCCCATTTCCATGAca	NULL
@	NULL
TeatTaaTTA	NULL
AchrT—_ck	NULL
:	NULL
cccms	NULL
ACGTGCCGAG	NULL
Tos	NULL
)	NULL
‘	NULL
~~	NULL
``	NULL
¢	NULL
``	NULL
``	NULL
\	NULL
«	NULL
E2	NULL
__	NULL
BstXi1~	NULL
Dral	NULL
___	NULL
``	NULL
Apal	NULL
-|	NULL
Ta2	NULL
-	NULL
To3	NULL
J_	NULL
II~	NULL
|	NULL
1	NULL
~1	NULL
16	NULL
22k	NULL
``	NULL
275	NULL
GCaACCCTrTGAAG	NULL
TCTCCCGCAGAAGCCA_	NULL
Ets	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

A	NULL
schematic	NULL
illustration	NULL
of	NULL
the	NULL
275	NULL
bp	NULL
BstX1/Apal	NULL
human	NULL
a	NULL
TCR	NULL
enhancer	NULL
``	NULL
.	NULL

The	NULL
location	NULL
of	NULL
the	NULL
Dral	NULL
restriction	NULL
endonuclease	NULL
site	NULL
,	NULL
and	NULL
the	NULL
locations	NULL
and	NULL
sequences	NULL
of	NULL
the	NULL
four	NULL
nuclear	NULL
protein-binding	NULL
sites	NULL
within	NULL
the	NULL
enhancer	NULL
(	NULL
Ta1-Ta4	NULL
)	NULL
are	NULL
shown	NULL
``	NULL
.	NULL

Sequences	NULL
corresponding	NULL
to	NULL
the	NULL
cAMP	NULL
response	NULL
element	NULL
(	NULL
CRE	NULL
)	NULL
,	NULL
and	NULL
the	NULL
GATA	NULL
,	NULL
TCF-1/LEF-1	NULL
,	NULL
Ets	NULL
and	NULL
AP-2-binding	NULL
sites	NULL
are	NULL
boxed	NULL
.	NULL

The	NULL
potential	NULL
xE2-binding	NULL
site	NULL
in	NULL
Ta3	NULL
is	NULL
underlined	NULL
.	NULL

within	NULL
the	NULL
core	NULL
of	NULL
the	NULL
CRE	NULL
and	NULL
no	NULL
Ta1-binding	NULL
proteins	NULL
were	NULL
detected	NULL
that	NULL
recognized	NULL
non-CRE	NULL
sequences	NULL
(	NULL
Ref	NULL
.	NULL

19	NULL
and	NULL
I-C.	NULL
Ho	NULL
and	NULL
J.M	NULL
.	NULL

Leiden	NULL
,	NULL
unpublished	NULL
)	NULL
.	NULL

Similar	NULL
EMSAs	NULL
demonstrated	NULL
that	NULL
Ta2	NULL
binds	NULL
at	NULL
least	NULL
four	NULL
nuclear	NULL
protein	NULL
complexes	NULL
.	NULL

One	NULL
of	NULL
these	NULL
is	NULL
T	NULL
cell	NULL
specific	NULL
while	NULL
a	NULL
second	NULL
is	NULL
present	NULL
in	NULL
all	NULL
T-cell	NULL
,	NULL
and	NULL
some	NULL
B-cell	NULL
,	NULL
nuclear	NULL
extracts	NULL
.	NULL

Ta3	NULL
binds	NULL
three	NULL
nuclear	NULL
protein	NULL
com-plexes	NULL
,	NULL
one	NULL
of	NULL
which	NULL
is	NULL
T	NULL
cell	NULL
specific	NULL
.	NULL

Finally	NULL
,	NULL
Tad4	NULL
binds	NULL
three	NULL
ubiquitously	NULL
expressed	NULL
nuclear	NULL
protein	NULL
complexes	NULL
.	NULL

Interestingly	NULL
,	NULL
none	NULL
of	NULL
these	NULL
experiments	NULL
identified	NULL
eB	NULL
TCR	NULL
lineage-specific	NULL
nuclear	NULL
protein	NULL
complexes	NULL
.	NULL

More	NULL
recent	NULL
studies	NULL
have	NULL
focused	NULL
on	NULL
the	NULL
cloning	NULL
of	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
«	NULL
TCR	NULL
enhancer	NULL
.	NULL

These	NULL
factors	NULL
are	NULL
described	NULL
individually	NULL
below	NULL
and	NULL
their	NULL
properties	NULL
are	NULL
summarized	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

CREB	NULL
proteins	NULL
bind	NULL
to	NULL
Tal	NULL
Southwestern	NULL
screening	NULL
of	NULL
a	NULL
Agt11	NULL
cDNA	NULL
expression	NULL
library	NULL
from	NULL
human	NULL
Jurkat	NULL
T	NULL
cells	NULL
with	NULL
a	NULL
radiolabelled	NULL
Tal	NULL
oligonucleotide	NULL
probe	NULL
allowed	NULL
the	NULL
identification	NULL
of	NULL
three	NULL
clones	NULL
that	NULL
encode	NULL
Tal-binding	NULL
proteins	NULL
(	NULL
B.A	NULL
.	NULL

Karpinski	NULL
et	NULL
al	NULL
.	NULL

,	NULL
submitted	NULL
)	NULL
.	NULL

DNA	NULL
sequence	NULL
analysis	NULL
of	NULL
these	NULL
clones	NULL
demonstrated	NULL
that	NULL
they	NULL
correspond	NULL
to	NULL
three	NULL
previously	NULL
identified	NULL
cDNAs	NULL
of	NULL
the	NULL
CREB	NULL
or	NULL
ATF	NULL
families	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

The	NULL
first	NULL
clone	NULL
corresponded	NULL
to	NULL
CREB	NULL
,	NULL
a	NULL
43	NULL
kDa	NULL
transcription	NULL
factor	NULL
that	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
CRE	NULL
sites	NULL
in	NULL
several	NULL
viral	NULL
and	NULL
cellular	NULL
enhancers	NULL
,	NULL
and	NULL
to	NULL
confer	NULL
cAMP-dependent	NULL
transcriptional	NULL
activation	NULL
on	NULL
these	NULL
The	NULL
second	NULL
clone	NULL
corresponded	NULL
to	NULL
a	NULL
cDNA	NULL
called	NULL
CRE-BP1	NULL
(	NULL
Ref	NULL
.	NULL

22	NULL
)	NULL
,	NULL
mXBP	NULL
or	NULL
ATF-2	NULL
(	NULL
Ref	NULL
.	NULL

24	NULL
)	NULL
;	NULL
this	NULL
protein	NULL
also	NULL
binds	NULL
with	NULL
high	NULL
affinity	NULL
to	NULL
CRE	NULL
sites	NULL
in	NULL
several	NULL
adenovirus	NULL
promoters	NULL
,	NULL
as	NULL
well	NULL
as	NULL
to	NULL
the	NULL
X	NULL
box	NULL
of	NULL
mouse	NULL
MHC	NULL
class	NULL
II	NULL
promoters	NULL
``	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
binding	NULL
of	NULL
this	NULL
protein	NULL
to	NULL
CRE	NULL
sites	NULL
in	NULL
several	NULL
adenovirus	NULL
promoters	NULL
confers	NULL
responsiveness	NULL
to	NULL
the	NULL
viral	NULL
E1A	NULL
pro-tein'*	NULL
.	NULL

The	NULL
final	NULL
clone	NULL
identified	NULL
was	NULL
a	NULL
full-length	NULL
hom-olog	NULL
of	NULL
a	NULL
partial-length	NULL
cDNA	NULL
,	NULL
previously	NULL
called	NULL
ATF-4	NULL
Table	NULL
1	NULL
.	NULL

Transcription	NULL
factors	NULL
that	NULL
regulate	NULL
the	NULL
«	NULL
TCR	NULL
enhancer	NULL
Transcription	NULL
Binding	NULL
Molecular	NULL
DNA-binding	NULL
Recognition	NULL
Lineage	NULL
Refs	NULL
factor	NULL
site	NULL
mass	NULL
domain	NULL
sequence	NULL
specificity	NULL
CREB	NULL
Tal	NULL
--	NULL
43kDa	NULL
Pasic	NULL
domain	NULL
'	NULL
___	NULL
TCACGTCA	NULL
_	NULL
Ubiquitous	NULL
20,21	NULL
eucine	NULL
zipper	NULL
CRE-BPI/ATF-2/	NULL
Basic	NULL
domain/	NULL
ols	NULL
mXBP	NULL
Tal	NULL
55	NULL
kDa	NULL
leucine	NULL
zipper	NULL
TCACGTCA	NULL
Ubiquitous	NULL
22-24	NULL
ATF4	NULL
Tal	NULL
--	NULL
38	NULL
kDa	NULL
hasic	NULL
domain	NULL
'	NULL
__	NULL
reaCGTCA	NULL
-_	NULL
Ubiquitous	NULL
24	NULL
eucine	NULL
zipper	NULL
CA_C	NULL
,	NULL
_GAA	NULL
TCF-1	NULL
Tal	NULL
30	NULL
kD	NULL
HMG	NULL
b	NULL
o	NULL
a	NULL
ox	NULL
TCTTT	NULL
TT	NULL
T	NULL
cells	NULL
31,32	NULL
CA_C	NULL
,	NULL
_GAA	NULL
T	NULL
cells/	NULL
Ta2	NULL
53-57	NULL
kDa	NULL
HMG	NULL
box	NULL
TCTTT	NULL
9T	NULL
Pre-B	NULL
cells	NULL
29,30	NULL
Basic	NULL
domain/	NULL
Ar	NULL
asic	NULL
domain	NULL
Ets-1	NULL
Ta2	NULL
54-60	NULL
kDa	NULL
a	NULL
helix	NULL
GAGGAAGCG	NULL
T	NULL
cells/B	NULL
cells	NULL
33	NULL
CC	NULL
TC	NULL
GATA-3	NULL
Ta3	NULL
--	NULL
47kDa	NULL
2	NULL
Cx	NULL
zinc	NULL
fingers	NULL
AGATA	NULL
I	NULL
cells/kidney/	NULL
_	NULL
59_5	NULL
,	NULL
T	NULL
G	NULL
brain	NULL
Immunology	NULL
Today	NULL
24	NULL
Vol	NULL
.	NULL

13	NULL
No	NULL
.	NULL

1	NULL
1992	NULL
REVIEW	NULL
(	NULL
Ref	NULL
.	NULL

24	NULL
)	NULL
.	NULL

The	NULL
function	NULL
of	NULL
ATF-4	NULL
remains	NULL
unknown	NULL
;	NULL
however	NULL
,	NULL
unpublished	NULL
studies	NULL
from	NULL
our	NULL
laboratory	NULL
have	NULL
demonstrated	NULL
that	NULL
overexpression	NULL
of	NULL
ATF-4	NULL
in	NULL
monkey	NULL
CV-1	NULL
cells	NULL
specifically	NULL
downregulates	NULL
cAMP-dependent	NULL
transcription	NULL
from	NULL
-	NULL
the	NULL
proenkephalin	NULL
-	NULL
promoter/	NULL
enhancer	NULL
.	NULL

Thus	NULL
,	NULL
at	NULL
least	NULL
in	NULL
certain	NULL
cell	NULL
types	NULL
,	NULL
ATF-4	NULL
may	NULL
represent	NULL
a	NULL
repressor	NULL
of	NULL
CRE-dependent	NULL
transcription	NULL
.	NULL

The	NULL
identities	NULL
of	NULL
the	NULL
additional	NULL
one	NULL
to	NULL
three	NULL
CREB	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
Tal	NULL
,	NULL
and	NULL
the	NULL
function	NULL
of	NULL
each	NULL
of	NULL
the	NULL
CREB	NULL
proteins	NULL
in	NULL
regulating	NULL
T-cell	NULL
transcription	NULL
are	NULL
unknown	NULL
.	NULL

As	NULL
described	NULL
in	NULL
more	NULL
detail	NULL
below	NULL
,	NULL
a	NULL
large	NULL
number	NULL
of	NULL
T-cell	NULL
enhancers	NULL
and	NULL
promoters	NULL
contain	NULL
CRE	NULL
sites	NULL
that	NULL
are	NULL
important	NULL
for	NULL
their	NULL
transcriptional	NULL
activity	NULL
.	NULL

Moreover	NULL
,	NULL
all	NULL
T	NULL
cells	NULL
contain	NULL
multiple	NULL
CRE-binding	NULL
proteins	NULL
,	NULL
although	NULL
no	NULL
T-cell-specific	NULL
CREB	NULL
protein	NULL
has	NULL
so	NULL
far	NULL
been	NULL
identified	NULL
.	NULL

It	NULL
is	NULL
worth	NULL
mentioning	NULL
that	NULL
the	NULL
name	NULL
CREB	NULL
may	NULL
be	NULL
a	NULL
misnomer	NULL
.	NULL

Although	NULL
members	NULL
of	NULL
the	NULL
CREB/ATF	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
are	NULL
important	NULL
in	NULL
regulating	NULL
transcription	NULL
in	NULL
response	NULL
to	NULL
alterations	NULL
in	NULL
intracellular	NULL
cAMP	NULL
levels	NULL
,	NULL
they	NULL
also	NULL
play	NULL
important	NULL
roles	NULL
in	NULL
modulating	NULL
basal	NULL
levels	NULL
of	NULL
transcription	NULL
,	NULL
and	NULL
have	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
upregulate	NULL
transcription	NULL
in	NULL
response	NULL
to	NULL
alterations	NULL
in	NULL
intracellular	NULL
calcium	NULL
levels	NULL
in	NULL
neural	NULL
cells*	NULL
``	NULL
.	NULL

Thus	NULL
,	NULL
their	NULL
precise	NULL
role	NULL
in	NULL
regulating	NULL
transcription	NULL
in	NULL
T	NULL
cells	NULL
awaits	NULL
studies	NULL
using	NULL
trans-dominant	NULL
inhibitors	NULL
and	NULL
embryonic	NULL
stem	NULL
(	NULL
ES	NULL
)	NULL
cell	NULL
gene	NULL
knock-out	NULL
experiments	NULL
,	NULL
both	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

TCF/LEF	NULL
proteins	NULL
bind	NULL
to	NULL
Ta	NULL
?	NULL

Several	NULL
recent	NULL
reports	NULL
have	NULL
described	NULL
the	NULL
purification	NULL
and	NULL
cloning	NULL
of	NULL
two	NULL
related	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
a	NULL
pyrimidine-rich	NULL
sequence	NULL
(	NULL
PyCTTTG/TT/AT/A	NULL
)	NULL
from	NULL
the	NULL
5	NULL
end	NULL
of	NULL
Ta2	NULL
(	NULL
as	NULL
well	NULL
as	NULL
to	NULL
a	NULL
related	NULL
motif	NULL
in	NULL
the	NULL
CD3e	NULL
enhancer	NULL
)	NULL
``	NULL
.	NULL

These	NULL
two	NULL
factors	NULL
,	NULL
called	NULL
TCF-1	NULL
(	NULL
Ref	NULL
.	NULL

3	NULL
1	NULL
)	NULL
and	NULL
TCF-1	NULL
@	NULL
``	NULL
°	NULL
(	NULL
or	NULL
LEF-1	NULL
(	NULL
Ref	NULL
.	NULL

30	NULL
)	NULL
)	NULL
,	NULL
are	NULL
approximately	NULL
30	NULL
kDa	NULL
and	NULL
53-57	NULL
kDa	NULL
proteins	NULL
containing	NULL
closely	NULL
related	NULL
80-90	NULL
amino	NULL
acid	NULL
DNA-binding	NULL
domains	NULL
that	NULL
display	NULL
significant	NULL
homology	NULL
to	NULL
a	NULL
region	NULL
present	NULL
in	NULL
the	NULL
high	NULL
mobility	NULL
group	NULL
(	NULL
HMG	NULL
)	NULL
family	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
.	NULL

Whereas	NULL
LEF-1	NULL
appears	NULL
to	NULL
be	NULL
the	NULL
mouse	NULL
hom-olog	NULL
of	NULL
TCF-l	NULL
«	NULL
,	NULL
TCF-1	NULL
is	NULL
apparently	NULL
encoded	NULL
by	NULL
a	NULL
distinct	NULL
gene	NULL
.	NULL

Studies	NULL
of	NULL
the	NULL
expression	NULL
patterns	NULL
of	NULL
these	NULL
genes	NULL
have	NULL
demonstrated	NULL
that	NULL
LEF-1	NULL
is	NULL
expressed	NULL
during	NULL
all	NULL
stages	NULL
of	NULL
T-cell	NULL
development	NULL
,	NULL
in	NULL
both	NULL
the	NULL
«	NULL
B	NULL
TCR	NULL
and	NULL
38	NULL
TCR	NULL
lineages	NULL
,	NULL
and	NULL
in	NULL
mouse	NULL
pre-B	NULL
cells	NULL
}	NULL
®	NULL
.	NULL

TCF-1	NULL
was	NULL
reported	NULL
to	NULL
be	NULL
expressed	NULL
exclusively	NULL
in	NULL
T	NULL
cells	NULL
'	NULL
!	NULL

but	NULL
a	NULL
comprehensive	NULL
examination	NULL
of	NULL
TCF-1	NULL
expression	NULL
at	NULL
different	NULL
stages	NULL
of	NULL
B-cell	NULL
development	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
reported	NULL
,	NULL
and	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
it	NULL
is	NULL
also	NULL
expressed	NULL
transiently	NULL
in	NULL
early	NULL
B	NULL
cells	NULL
.	NULL

Overexpression	NULL
of	NULL
both	NULL
TCF-1	NULL
and	NULL
TCF-1I	NULL
@	NULL
/LEF-1	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
HeLa	NULL
cells	NULL
or	NULL
COS	NULL
cells	NULL
leads	NULL
to	NULL
low	NULL
level	NULL
(	NULL
3-20-fold	NULL
)	NULL
trans-activation	NULL
of	NULL
reporter	NULL
constructs	NULL
containing	NULL
TCF-1-binding	NULL
sites	NULL
from	NULL
the	NULL
«	NULL
TCR	NULL
or	NULL
CD3e	NULL
``	NULL
.	NULL

However	NULL
,	NULL
trans-activation	NULL
by	NULL
LEF-1	NULL
and	NULL
TCF-1a	NULL
@	NULL
appears	NULL
to	NULL
require	NULL
the	NULL
presence	NULL
of	NULL
additional	NULL
nuclear	NULL
protein-binding	NULL
sites	NULL
because	NULL
overexpression	NULL
of	NULL
these	NULL
factors	NULL
can	NULL
not	NULL
trans-activate	NULL
a	NULL
reporter	NULL
construct	NULL
containing	NULL
only	NULL
multimerized	NULL
TCF/LEF-1-binding	NULL
sites	NULL
upstream	NULL
of	NULL
a	NULL
minimal	NULL
Multiple	NULL
forms	NULL
of	NULL
both	NULL
the	NULL
TCF-1	NULL
and	NULL
TCF-1e/LEF-1	NULL
proteins	NULL
appear	NULL
to	NULL
be	NULL
generated	NULL
by	NULL
alternative	NULL
splicing	NULL
.	NULL

These	NULL
include	NULL
variants	NULL
of	NULL
TCF-1	NULL
,	NULL
containing	NULL
or	NULL
lacking	NULL
a	NULL
Inumunology	NULL
Today	NULL
25	NULL
proline-rich	NULL
domain	NULL
amino-terminal	NULL
to	NULL
the	NULL
HMG	NULL
box	NULL
,	NULL
as	NULL
well	NULL
as	NULL
multiple	NULL
forms	NULL
of	NULL
the	NULL
protein	NULL
with	NULL
distinct	NULL
carboxy-terminal	NULL
regions	NULL
,	NULL
including	NULL
one	NULL
which	NULL
is	NULL
rich	NULL
in	NULL
serine	NULL
and	NULL
threonine	NULL
residues*	NULL
'	NULL
>	NULL
.	NULL

Similarly	NULL
,	NULL
two	NULL
splice	NULL
variants	NULL
of	NULL
TCF-l	NULL
a	NULL
have	NULL
been	NULL
described	NULL
,	NULL
which	NULL
contain	NULL
or	NULL
lack	NULL
a	NULL
serine-threonine-rich	NULL
domain	NULL
,	NULL
immediately	NULL
amino-terminal	NULL
to	NULL
the	NULL
HMG	NULL
box	NULL
``	NULL
``	NULL
.	NULL

The	NULL
DNA-binding	NULL
activities	NULL
and	NULL
trans-activation	NULL
potentials	NULL
of	NULL
these	NULL
alternatively	NULL
spliced	NULL
variants	NULL
have	NULL
not	NULL
been	NULL
studied	NULL
in	NULL
detail	NULL
but	NULL
it	NULL
seems	NULL
likely	NULL
that	NULL
the	NULL
activities	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
may	NULL
be	NULL
regulated	NULL
at	NULL
both	NULL
post-transcriptional	NULL
and	NULL
post-translational	NULL
levels	NULL
.	NULL

Ets	NULL
proteins	NULL
bind	NULL
to	NULL
Ta	NULL
?	NULL

Using	NULL
a	NULL
Agt11	NULL
expression	NULL
screening	NULL
approach	NULL
,	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL
``	NULL

}	NULL
demonstrated	NULL
that	NULL
the	NULL
protein	NULL
product	NULL
of	NULL
the	NULL
Ets-1	NULL
proto-oncogene	NULL
binds	NULL
specifically	NULL
to	NULL
a	NULL
purine-rich	NULL
sequence	NULL
(	NULL
GAGGATGTG	NULL
)	NULL
located	NULL
at	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
Ta2	NULL
.	NULL

Along	NULL
with	NULL
several	NULL
simultaneous	NULL
reports'*~	NULL
``	NULL
,	NULL
this	NULL
was	NULL
the	NULL
first	NULL
demonstration	NULL
that	NULL
the	NULL
Ets	NULL
proto-oncogenes	NULL
encode	NULL
sequence-specific	NULL
DNA-binding	NULL
proteins	NULL
.	NULL

Binding	NULL
of	NULL
Ets-	NULL
I	NULL
to	NULL
the	NULL
«	NULL
TCR	NULL
enhancer	NULL
was	NULL
especially	NULL
i	NULL
intriguing	NULL
because	NULL
Ets-1	NULL
is	NULL
known	NULL
to	NULL
be	NULL
expressed	NULL
preferentially	NULL
in	NULL
thymocytes	NULL
and	NULL
T	NULL
cells	NULL
(	NULL
as	NULL
well	NULL
as	NULL
B	NULL
cells	NULL
)	NULL
}	NULL
,	NULL
and	NULL
because	NULL
its	NULL
expression	NULL
is	NULL
developmentally	NULL
regulated	NULL
during	NULL
thymic	NULL
ontogeny	NULL
,	NULL
with	NULL
a	NULL
time	NULL
course	NULL
that	NULL
is	NULL
almost	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
the	NULL
«	NULL
TCR	NULL
gene	NULL
:	NULL
both	NULL
are	NULL
first	NULL
expressed	NULL
on	NULL
days	NULL
17	NULL
and	NULL
18	NULL
in	NULL
the	NULL
fetal	NULL
mouse	NULL
thymus*	NULL
``	NULL
.	NULL

Thus	NULL
,	NULL
Ets-	NULL
1	NULL
is	NULL
a	NULL
candidate	NULL
trigger	NULL
factor	NULL
for	NULL
«	NULL
TCR	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
the	NULL
Ets-1	NULL
-binding	NULL
site	NULL
for	NULL
«	NULL
TCR	NULL
enhancer	NULL
function	NULL
was	NULL
demonstrated	NULL
by	NULL
experiments	NULL
showing	NULL
that	NULL
mutations	NULL
in	NULL
the	NULL
core	NULL
Ets-1-binding	NULL
site	NULL
in	NULL
Ta2	NULL
abolished	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
minimal	NULL
«	NULL
TCR	NULL
enhancer	NULL
in	NULL
Jurkat	NULL
cells	NULL
``	NULL
}	NULL
.	NULL

Thus	NULL
far	NULL
,	NULL
however	NULL
,	NULL
overexpression	NULL
of	NULL
Ets-1	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
in	NULL
nonlymphoid	NULL
cells	NULL
has	NULL
not	NULL
resulted	NULL
in	NULL
the	NULL
trans-activation	NULL
of	NULL
the	NULL
a	NULL
TCR	NULL
enhancer	NULL
(	NULL
I-C.	NULL
Ho	NULL
and	NULL
J.M	NULL
.	NULL

Leiden	NULL
,	NULL
unpublished	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
other	NULL
T-cell-specific	NULL
factors	NULL
may	NULL
be	NULL
required	NULL
for	NULL
trans-activation	NULL
of	NULL
the	NULL
«	NULL
TCR	NULL
enhancer	NULL
by	NULL
Ets-1	NULL
(	NULL
for	NULL
example	NULL
,	NULL
TCF/LEF	NULL
factors	NULL
or	NULL
GATA-3	NULL
)	NULL
or	NULL
that	NULL
other	NULL
Ets	NULL
family	NULL
members	NULL
may	NULL
regulate	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
«	NULL
TCR	NULL
enhancer	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

(	NULL
Evidence	NULL
from	NULL
several	NULL
sources	NULL
suggests	NULL
that	NULL
Ets	NULL
proteins	NULL
usually	NULL
require	NULL
additional	NULL
transcription	NULL
factors	NULL
to	NULL
communicate	NULL
with	NULL
the	NULL
basal	NULL
transcription	NULL
ma-chinery	NULL
?	NULL
}	NULL

.	NULL
)	NULL

Alternatively	NULL
,	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
Ets-1	NULL
may	NULL
require	NULL
post-translational	NULL
modification	NULL
,	NULL
and	NULL
Ets-1	NULL
is	NULL
known	NULL
to	NULL
exist	NULL
in	NULL
both	NULL
phosphorylated	NULL
and	NULL
nonphosphorylated	NULL
forms	NULL
in	NULL
T	NULL
cellst	NULL
'	NULL
.	NULL

Each	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
members	NULL
contains	NULL
a	NULL
conserved	NULL
basic	NULL
domain	NULL
and	NULL
an	NULL
adjacent	NULL
region	NULL
with	NULL
predicted	NULL
a-helical	NULL
structure	NULL
?	NULL

.	NULL

Using	NULL
deletion	NULL
and	NULL
mutation	NULL
analy-ses	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
both	NULL
of	NULL
these	NULL
conserved	NULL
regions	NULL
are	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
DNA	NULL
binding	NULL
(	NULL
C-Y	NULL
.	NULL

Wang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
submitted	NULL
)	NULL
.	NULL

Only	NULL
two	NULL
Ets	NULL
family	NULL
members	NULL
,	NULL
Ets-1	NULL
and	NULL
Ets-2	NULL
,	NULL
were	NULL
previously	NULL
known	NULL
to	NULL
be	NULL
expressed	NULL
in	NULL
T	NULL
cells	NULL
?	NULL

``	NULL
.	NULL

However	NULL
,	NULL
by	NULL
using	NULL
low	NULL
stringency	NULL
hybridization	NULL
with	NULL
a	NULL
cDNA	NULL
fragment	NULL
encompassing	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
Ets-1	NULL
,	NULL
we	NULL
have	NULL
recently	NULL
isolated	NULL
two	NULL
additional	NULL
and	NULL
novel	NULL
Ets	NULL
family	NULL
members	NULL
from	NULL
a	NULL
Jurkat	NULL
T-cell	NULL
cDNA	NULL
library	NULL
.	NULL

One	NULL
of	NULL
these	NULL
clones	NULL
,	NULL
called	NULL
Elf-1	NULL
,	NULL
contains	NULL
a	NULL
DNA-binding	NULL
domain	NULL
that	NULL
is	NULL
almost	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
the	NULL
Drosophila	NULL
transcription	NULL
factor	NULL
,	NULL
E74	NULL
(	NULL
Ref	NULL
.	NULL

36	NULL
)	NULL
(	NULL
hence	NULL
the	NULL
name	NULL
E74-like	NULL
factor-1	NULL
)	NULL
(	NULL
C.B	NULL
.	NULL

Vol	NULL
.	NULL

13	NULL
No	NULL
.	NULL

1	NULL
1992	NULL
REVIEW	NULL
Thompson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
submitted	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
this	NULL
factor	NULL
binds	NULL
to	NULL
several	NULL
T-cell	NULL
transcriptional	NULL
regulatory	NULL
regions	NULL
,	NULL
including	NULL
the	NULL
IL-2	NULL
enhancer	NULL
and	NULL
the	NULL
CD3R	NULL
site	NULL
of	NULL
the	NULL
HIV-2	NULL
enhancer4	NULL
,	NULL
but	NULL
not	NULL
to	NULL
the	NULL
Ets-binding	NULL
sites	NULL
within	NULL
the	NULL
«	NULL
TCR	NULL
or	NULL
B	NULL
TCR	NULL
enhancers	NULL
.	NULL

The	NULL
other	NULL
novel	NULL
factor	NULL
,	NULL
which	NULL
we	NULL
have	NULL
called	NULL
Ets-4	NULL
,	NULL
contains	NULL
a	NULL
DNA-binding	NULL
domain	NULL
that	NULL
is	NULL
more	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
Ets-1	NULL
and	NULL
Ets-2	NULL
,	NULL
and	NULL
binds	NULL
to	NULL
both	NULL
the	NULL
a	NULL
and	NULL
B	NULL
TCR	NULL
enhancers®	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
multiple	NULL
Ets	NULL
family	NULL
members	NULL
are	NULL
expressed	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
that	NULL
these	NULL
family	NULL
members	NULL
display	NULL
distinct	NULL
DNA-binding	NULL
specificities	NULL
that	NULL
allow	NULL
them	NULL
to	NULL
interact	NULL
independently	NULL
with	NULL
,	NULL
and	NULL
regulate	NULL
,	NULL
multiple	NULL
T-cell	NULL
genes	NULL
.	NULL

Mutational	NULL
analyses	NULL
of	NULL
several	NULL
different	NULL
Ets-binding	NULL
sites	NULL
have	NULL
demonstrated	NULL
that	NULL
nucleotides	NULL
at	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
Ets-binding	NULL
sites	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
differential	NULL
binding	NULL
activities	NULL
of	NULL
some	NULL
of	NULL
the	NULL
different	NULL
Ets	NULL
family	NULL
members	NULL
.	NULL

As	NULL
is	NULL
the	NULL
case	NULL
for	NULL
the	NULL
CREB	NULL
and	NULL
TCF/	NULL
LEF	NULL
proteins	NULL
,	NULL
a	NULL
complete	NULL
understanding	NULL
of	NULL
the	NULL
functions	NULL
of	NULL
each	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
members	NULL
awaits	NULL
gene	NULL
knock-out	NULL
and	NULL
trans-dominant	NULL
inhibitor	NULL
experiments	NULL
,	NULL
in	NULL
both	NULL
cell	NULL
lines	NULL
and	NULL
mice	NULL
.	NULL

GATA	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
Ta3	NULL
GATA-1	NULL
(	NULL
previously	NULL
called	NULL
Eryf-1	NULL
and	NULL
GF-1	NULL
)	NULL
is	NULL
a	NULL
zinc	NULL
finger	NULL
protein	NULL
that	NULL
is	NULL
expressed	NULL
exclusively	NULL
in	NULL
erythroid	NULL
cells	NULL
,	NULL
megakaryocytes	NULL
,	NULL
mast	NULL
cells	NULL
and	NULL
their	NULL
common	NULL
progenitors**-*	NULL
``	NULL
.	NULL

This	NULL
factor	NULL
is	NULL
a	NULL
transcriptional	NULL
activator	NULL
that	NULL
binds	NULL
to	NULL
a	NULL
sequence	NULL
,	NULL
A/TGATAA/G	NULL
,	NULL
which	NULL
is	NULL
present	NULL
in	NULL
the	NULL
transcriptional	NULL
regulatory	NULL
regions	NULL
of	NULL
a	NULL
number	NULL
of	NULL
erythroid-specific	NULL
genes	NULL
including	NULL
the	NULL
«	NULL
,	NULL
B	NULL
and	NULL
8	NULL
globin	NULL
genes*®	NULL
.	NULL

Recent	NULL
experiments	NULL
,	NULL
in	NULL
which	NULL
GATA-1	NULL
gene	NULL
expression	NULL
has	NULL
been	NULL
abolished	NULL
by	NULL
homologous	NULL
recombination	NULL
in	NULL
embryonic	NULL
stem	NULL
cells	NULL
,	NULL
have	NULL
demonstrated	NULL
that	NULL
GATA-1	NULL
is	NULL
required	NULL
for	NULL
the	NULL
development	NULL
of	NULL
the	NULL
erythroid	NULL
lineage	NULL
in	NULL
mice*	NULL
.	NULL

Thus	NULL
,	NULL
GATA-1	NULL
belongs	NULL
to	NULL
the	NULL
small	NULL
family	NULL
of	NULL
lineage-specific	NULL
determination	NULL
genes	NULL
.	NULL

An	NULL
examination	NULL
of	NULL
the	NULL
Ta3	NULL
motif	NULL
of	NULL
the	NULL
a	NULL
TCR	NULL
enhancer	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
consensus	NULL
binding	NULL
site	NULL
{	NULL
(	NULL
AGATAG	NULL
)	NULL
for	NULL
GATA-1	NULL
.	NULL

Since	NULL
GATA-1	NULL
is	NULL
not	NULL
expressed	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
this	NULL
finding	NULL
raised	NULL
the	NULL
possibility	NULL
that	NULL
there	NULL
is	NULL
a	NULL
distinct	NULL
T-cell	NULL
GATA	NULL
protein	NULL
that	NULL
binds	NULL
to	NULL
this	NULL
site	NULL
.	NULL

To	NULL
address	NULL
this	NULL
question	NULL
,	NULL
a	NULL
Jurkat	NULL
T-cell	NULL
cDNA	NULL
library	NULL
was	NULL
screened	NULL
by	NULL
low	NULL
stringency	NULL
hybridization	NULL
with	NULL
a	NULL
cDNA	NULL
probe	NULL
from	NULL
the	NULL
zinc	NULL
finger	NULL
region	NULL
of	NULL
GATA-1	NULL
.	NULL

These	NULL
experiments	NULL
resulted	NULL
in	NULL
the	NULL
isolation	NULL
of	NULL
a	NULL
novel	NULL
cDNA	NULL
called	NULL
hGATA-3	NULL
(	NULL
Ref	NULL
.	NULL

50	NULL
)	NULL
.	NULL

The	NULL
chicken	NULL
(	NULL
cGATA-3	NULL
)	NULL
and	NULL
mouse	NULL
(	NULL
mGATA-3	NULL
)	NULL
homologs	NULL
of	NULL
hGATA-3	NULL
were	NULL
isolated	NULL
using	NULL
a	NULL
similar	NULL
approach	NULL
``	NULL
``	NULL
.	NULL

hGATA-3	NULL
is	NULL
a	NULL
48	NULL
kDa	NULL
polypeptide	NULL
that	NULL
contains	NULL
two	NULL
zinc	NULL
fingers	NULL
that	NULL
are	NULL
more	NULL
than	NULL
90	NULL
%	NULL
identical	NULL
to	NULL
those	NULL
of	NULL
GATA-1	NULL
(	NULL
Ref	NULL
.	NULL

50	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
remainder	NULL
of	NULL
the	NULL
protein	NULL
is	NULL
less	NULL
than	NULL
12	NULL
%	NULL
identical	NULL
to	NULL
GATA-1	NULL
.	NULL

Studies	NULL
of	NULL
the	NULL
expression	NULL
pattern	NULL
of	NULL
hGATA-3	NULL
showed	NULL
that	NULL
,	NULL
within	NULL
hematopoietic	NULL
cells	NULL
,	NULL
its	NULL
expression	NULL
is	NULL
restricted	NULL
to	NULL
the	NULL
«	NULL
B	NULL
and	NULL
48	NULL
T-cell	NULL
lineages®®	NULL
.	NULL

Interestingly	NULL
,	NULL
a	NULL
slightly	NULL
larger	NULL
GATA-3	NULL
mRNA	NULL
is	NULL
expressed	NULL
in	NULL
kidney	NULL
and	NULL
in	NULL
some	NULL
mesangial	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
relationship	NULL
between	NULL
the	NULL
kidney	NULL
and	NULL
T-cell	NULL
GATA-3	NULL
mRNAs	NULL
has	NULL
not	NULL
been	NULL
established	NULL
.	NULL

Low	NULL
level	NULL
GATA-3	NULL
expression	NULL
was	NULL
also	NULL
detected	NULL
in	NULL
whole	NULL
brain	NULL
.	NULL

Overexpression	NULL
of	NULL
hGATA-3	NULL
(	NULL
as	NULL
well	NULL
as	NULL
cGATA-3	NULL
or	NULL
mGATA-3	NULL
)	NULL
in	NULL
nonlymphoid	NULL
cells	NULL
resulted	NULL
in	NULL
trans-activation	NULL
of	NULL
reporter	NULL
constructs	NULL
containing	NULL
multimerized	NULL
GATA	NULL
sites	NULL
from	NULL
Ta3	NULL
(	NULL
Ref	NULL
.	NULL

50	NULL
)	NULL
or	NULL
from	NULL
a	NULL
related	NULL
Immunology	NULL
Today	NULL
26	NULL
sequence	NULL
from	NULL
the	NULL
8	NULL
TCR	NULL
enhancer	NULL
(	NULL
8E4	NULL
)	NULL
*	NULL
upstream	NULL
of	NULL
a	NULL
minimal	NULL
promoter	NULL
.	NULL

Thus	NULL
,	NULL
unlike	NULL
the	NULL
TCF-1	NULL
«	NULL
/LEF-1	NULL
and	NULL
the	NULL
Ets	NULL
proteins	NULL
,	NULL
hGATA-3	NULL
can	NULL
trans-activate	NULL
transcription	NULL
from	NULL
its	NULL
cognate	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
additional	NULL
nuclear	NULL
protein-binding	NULL
sites	NULL
.	NULL

An	NULL
examination	NULL
of	NULL
mGATA-3	NULL
expression	NULL
during	NULL
thymocyte	NULL
development	NULL
has	NULL
demonstrated	NULL
expression	NULL
of	NULL
this	NULL
gene	NULL
in	NULL
the	NULL
earliest	NULL
thymocytes	NULL
tested	NULL
(	NULL
fetal	NULL
day	NULL
14	NULL
in	NULL
the	NULL
mouse	NULL
)	NULL
(	NULL
B.K	NULL
.	NULL

Oakley	NULL
and	NULL
J.M	NULL
.	NULL

Leiden	NULL
,	NULL
unpublished	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
like	NULL
TCF-1	NULL
and	NULL
TCF-1	NULL
&	NULL
@	NULL
/LEF-1	NULL
,	NULL
GATA-3	NULL
is	NULL
a	NULL
lineage-restricted	NULL
transcription	NULL
factor	NULL
that	NULL
is	NULL
expressed	NULL
very	NULL
early	NULL
in	NULL
T-cell	NULL
development	NULL
.	NULL

hGATA-3	NULL
was	NULL
also	NULL
shown	NULL
to	NULL
be	NULL
expressed	NULL
at	NULL
low	NULL
levels	NULL
in	NULL
CEM	NULL
cells	NULL
,	NULL
an	NULL
immature	NULL
T-cell	NULL
line	NULL
that	NULL
does	NULL
not	NULL
express	NULL
a	NULL
TCR	NULL
mRNA	NULL
.	NULL

However	NULL
,	NULL
after	NULL
stimulation	NULL
with	NULL
PMA	NULL
both	NULL
hGATA-3	NULL
and	NULL
a	NULL
TCR	NULL
mRNA	NULL
levels	NULL
increased	NULL
dramati-cally	NULL
``	NULL
.	NULL

(	NULL
Similar	NULL
findings	NULL
have	NULL
been	NULL
reported	NULL
for	NULL
TCF-l	NULL
«	NULL
in	NULL
this	NULL
system	NULL
?	NULL

.	NULL
)	NULL

These	NULL
findings	NULL
,	NULL
when	NULL
considered	NULL
with	NULL
the	NULL
previously	NULL
described	NULL
results	NULL
concerning	NULL
the	NULL
role	NULL
of	NULL
GATA-1	NULL
in	NULL
erythroid	NULL
differentiation	NULL
'	NULL
,	NULL
suggested	NULL
that	NULL
GATA-3	NULL
is	NULL
a	NULL
good	NULL
candidate	NULL
for	NULL
a	NULL
T-cell-determining	NULL
gene	NULL
.	NULL

This	NULL
possibility	NULL
is	NULL
currently	NULL
being	NULL
tested	NULL
by	NULL
using	NULL
homologous	NULL
recombination	NULL
to	NULL
eliminate	NULL
GATA-3	NULL
expression	NULL
in	NULL
embryonic	NULL
stem	NULL
cells	NULL
and	NULL
mice	NULL
.	NULL

Shared	NULL
nuclear	NULL
protein-binding	NULL
sites	NULL
in	NULL
multiple	NULL
T-cell	NULL
enhancers	NULL
and	NULL
promoters	NULL
The	NULL
studies	NULL
of	NULL
the	NULL
a	NULL
TCR	NULL
enhancer	NULL
described	NULL
above	NULL
were	NULL
predicated	NULL
on	NULL
the	NULL
hypothesis	NULL
that	NULL
transcription	NULL
factors	NULL
that	NULL
regulate	NULL
a	NULL
TCR	NULL
gene	NULL
expression	NULL
might	NULL
also	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
additional	NULL
T-cell	NULL
genes	NULL
.	NULL

This	NULL
should	NULL
be	NULL
particularly	NULL
true	NULL
for	NULL
factors	NULL
that	NULL
play	NULL
important	NULL
roles	NULL
in	NULL
regulating	NULL
lymphoid	NULL
and	NULL
T-cell	NULL
development	NULL
.	NULL

To	NULL
address	NULL
this	NULL
question	NULL
,	NULL
the	NULL
sequences	NULL
of	NULL
the	NULL
known	NULL
nuclear	NULL
protein-binding	NULL
sites	NULL
from	NULL
the	NULL
«	NULL
TCR	NULL
enhancer	NULL
have	NULL
been	NULL
compared	NULL
with	NULL
those	NULL
of	NULL
several	NULL
other	NULL
T-cell-specific	NULL
transcriptional	NULL
regulatory	NULL
regions	NULL
,	NULL
including	NULL
the	NULL
human	NULL
B	NULL
!	NULL

and	NULL
853	NULL
TCR	NULL
enhancers	NULL
,	NULL
the	NULL
CD2	NULL
enhancer	NULL
'	NULL
,	NULL
and	NULL
the	NULL
CD36	NULL
and	NULL
85°	NULL
enhancers	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
and	NULL
Table	NULL
2	NULL
,	NULL
each	NULL
of	NULL
these	NULL
enhancers	NULL
contains	NULL
different	NULL
combinations	NULL
of	NULL
binding	NULL
sites	NULL
for	NULL
CREB	NULL
,	NULL
TCF-1/LEF-1	NULL
,	NULL
Ets	NULL
,	NULL
GATA	NULL
and	NULL
E	NULL
box	NULL
proteins	NULL
.	NULL

In	NULL
some	NULL
cases	NULL
,	NULL
these	NULL
sites	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
the	NULL
relevant	NULL
proteins	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
a	NULL
TCR	NULL
gene	NULL
is	NULL
an	NULL
excellent	NULL
paradigm	NULL
of	NULL
T-cell-specific	NULL
transcriptional	NULL
regulation	NULL
,	NULL
and	NULL
it	NULL
appears	NULL
likely	NULL
that	NULL
each	NULL
of	NULL
these	NULL
families	NULL
of	NULL
transcription	NULL
factors	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
regulating	NULL
multiple	NULL
T-cell	NULL
genes	NULL
during	NULL
development	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Table	NULL
2	NULL
,	NULL
potential	NULL
Ets-binding	NULL
sites	NULL
can	NULL
also	NULL
be	NULL
found	NULL
in	NULL
the	NULL
transcriptional	NULL
regulatory	NULL
regions	NULL
of	NULL
multiple	NULL
lymphokine	NULL
genes	NULL
,	NULL
suggesting	NULL
that	NULL
Ets	NULL
family	NULL
members	NULL
may	NULL
also	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
regulating	NULL
gene	NULL
expression	NULL
during	NULL
the	NULL
process	NULL
of	NULL
T-cell	NULL
activation	NULL
;	NULL
for	NULL
example	NULL
,	NULL
at	NULL
least	NULL
one	NULL
functional	NULL
Ets-binding	NULL
site	NULL
is	NULL
required	NULL
for	NULL
IL-2	NULL
enhancer	NULL
function	NULL
.	NULL

Many	NULL
of	NULL
the	NULL
genes	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
are	NULL
expressed	NULL
at	NULL
different	NULL
times	NULL
in	NULL
development	NULL
,	NULL
in	NULL
some	NULL
cases	NULL
in	NULL
different	NULL
cell	NULL
lineages	NULL
,	NULL
and	NULL
,	NULL
in	NULL
others	NULL
,	NULL
only	NULL
after	NULL
cell	NULL
activation	NULL
.	NULL

How	NULL
,	NULL
then	NULL
,	NULL
are	NULL
these	NULL
genes	NULL
differentially	NULL
regulated	NULL
in	NULL
response	NULL
to	NULL
distinct	NULL
developmental	NULL
and	NULL
activational	NULL
sig-nals	NULL
,	NULL
if	NULL
they	NULL
contain	NULL
common	NULL
sets	NULL
of	NULL
nuclear	NULL
protein-binding	NULL
sites	NULL
?	NULL

While	NULL
the	NULL
answer	NULL
to	NULL
this	NULL
question	NULL
is	NULL
complex	NULL
and	NULL
not	NULL
yet	NULL
fully	NULL
understood	NULL
,	NULL
there	NULL
are	NULL
several	NULL
Vol	NULL
.	NULL

13	NULL
No	NULL
.	NULL

1	NULL
1992	NULL
REVIEW	NULL
(	NULL
Ta1	NULL
)	NULL
CRE*	NULL
(	NULL
T2	NULL
)	NULL
TCF-1*	NULL
(	NULL
Ta2	NULL
)	NULL
Ta2B*	NULL
(	NULL
T12	NULL
)	NULL
(	NULL
Ta3	NULL
)	NULL
GATA*	NULL
(	NULL
Ta3	NULL
)	NULL
E	NULL
box	NULL
«	NULL
TCR	NULL
Enh	NULL
—CGGTT—20bp—GCMTCw—zsbp—Arccccc	NULL
@	NULL
scecacerecc3	NULL
CRE	NULL
(	NULL
TB2	NULL
)	NULL
GATA*	NULL
(	NULL
TB2	NULL
)	NULL
CRE*	NULL
E	NULL
box	NULL
TCF-1	NULL
CD2	NULL
Enh	NULL
—CTATCTG—174bp—	NULL
@	NULL
—20bp	NULL
CRE*	NULL
TCF-1	NULL
Ta2B	NULL
Ets	NULL
CD36	NULL
Enh	NULL
GACATC	NULL
247bp	NULL
—€ACCCTT	NULL
%	NULL
CCACTGAGC§ATC€	NULL
TGCCTGCgZC	NULL
“	NULL
E	NULL
box	NULL
TCF	NULL
1	NULL
CD3e	NULL
Enh	NULL
rcaa	NULL
GGAGG	NULL
70bp	NULL
CAGGATG	NULL
+	NULL
56bp	NULL
CGGCAGCTGG	NULL
19bp	NULL
CGCTTTGT	NULL
(	NULL
TB3	NULL
)	NULL
Ets*	NULL
(	NULL
TBS	NULL
)	NULL
TCF-1*	NULL
B	NULL
TCR	NULL
Enh	NULL
GA	NULL
CACATCA	NULL
15bp	NULL
ccacertg	NULL
25bp	NULL
AACAGGATG	NULL
173bp	NULL
ACTTCAGAGGGqG	NULL
(	NULL
dE1	NULL
)	NULL
(	NULL
dE3	NULL
)	NULL
(	NULL
dE4	NULL
)	NULL
-	NULL
(	NULL
8E4	NULL
)	NULL
(	NULL
8E4	NULL
)	NULL
(	NULL
dE5	NULL
)	NULL
(	NULL
dE7	NULL
)	NULL
GATA	NULL
E	NULL
box	NULL
GATA*	NULL
GATA*	NULL
E	NULL
box	NULL
TCF-1	NULL
8	NULL
TCR	NULL
Enh	NULL
132bp	NULL
21bp	NULL
-	NULL
(	NULL
TGAT	NULL
TGATAZCAAGT	NULL
GGAAAC	NULL
)	NULL
46bP	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

A	NULL
comparison	NULL
of	NULL
potential	NULL
nuclear	NULL
protein-binding	NULL
sites	NULL
in	NULL
six	NULL
I	NULL
-cell	NULL
transcriptional	NULL
enhancers	NULL
.	NULL

Potential	NULL
nuclear	NULL
protein-binding	NULL
sites	NULL
are	NULL
boxed	NULL
.	NULL

Previously	NULL
described	NULL
names	NULL
of	NULL
these	NULL
binding	NULL
sites	NULL
within	NULL
each	NULL
enhancer	NULL
are	NULL
shown	NULL
in	NULL
parentheses	NULL
.	NULL

Binding	NULL
sites	NULL
that	NULL
have	NULL
been	NULL
demonstrated	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
relevant	NULL
proteit	NULL
are	NULL
denoted	NULL
with	NULL
an	NULL
asterisk	NULL
,	NULL
models	NULL
that	NULL
allow	NULL
a	NULL
significant	NULL
redundancy	NULL
in	NULL
the	NULL
cis-acting	NULL
regulatory	NULL
sequences	NULL
in	NULL
different	NULL
genes	NULL
,	NULL
while	NULL
retaining	NULL
the	NULL
potential	NULL
for	NULL
differential	NULL
expression	NULL
.	NULL

First	NULL
,	NULL
different	NULL
combinations	NULL
of	NULL
common	NULL
,	NULL
or	NULL
overlap-ping	NULL
,	NULL
sets	NULL
of	NULL
nuclear	NULL
protein-binding	NULL
sites	NULL
may	NULL
allow	NULL
flexible	NULL
patterns	NULL
of	NULL
expression	NULL
with	NULL
a	NULL
minimum	NULL
number	NULL
of	NULL
different	NULL
transcription	NULL
factors	NULL
.	NULL

Such	NULL
combinatorial	NULL
diversity	NULL
is	NULL
clearly	NULL
an	NULL
important	NULL
mechanism	NULL
underlying	NULL
the	NULL
generation	NULL
of	NULL
antigen	NULL
receptor	NULL
diversity	NULL
.	NULL

This	NULL
type	NULL
of	NULL
model	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
finding	NULL
that	NULL
interactions	NULL
between	NULL
transcription	NULL
factors	NULL
are	NULL
required	NULL
for	NULL
the	NULL
activity	NULL
of	NULL
many	NULL
of	NULL
the	NULL
T-cell-specific	NULL
enhancers	NULL
.	NULL

Second	NULL
,	NULL
different	NULL
members	NULL
of	NULL
a	NULL
single	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
may	NULL
display	NULL
different	NULL
DNA-binding	NULL
specificities	NULL
(	NULL
which	NULL
may	NULL
be	NULL
further	NULL
modified	NULL
by	NULL
post-transcriptional	NULL
or	NULL
post-translational	NULL
modifications	NULL
)	NULL
or	NULL
may	NULL
bind	NULL
preferentially	NULL
to	NULL
a	NULL
given	NULL
enhancer	NULL
in	NULL
combination	NULL
with	NULL
an	NULL
adjacent	NULL
nuclear	NULL
protein	NULL
.	NULL

Such	NULL
differences	NULL
in	NULL
DNA-binding	NULL
specificities	NULL
have	NULL
already	NULL
been	NULL
demonstrated	NULL
for	NULL
the	NULL
Ets	NULL
family	NULL
members	NULL
and	NULL
may	NULL
explain	NULL
how	NULL
this	NULL
single	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
regulates	NULL
the	NULL
expression	NULL
of	NULL
different	NULL
genes	NULL
in	NULL
resting	NULL
and	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Third	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
negative	NULL
regulatory	NULL
elements	NULL
or	NULL
silencers	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
restricting	NULL
the	NULL
lineage	NULL
specificity	NULL
of	NULL
certain	NULL
T-cell	NULL
genes	NULL
.	NULL

This	NULL
type	NULL
of	NULL
model	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
inability	NULL
to	NULL
detect	NULL
lineage-specific	NULL
transcriptional	NULL
activator	NULL
proteins	NULL
;	NULL
all	NULL
of	NULL
the	NULL
previously	NULL
described	NULL
a	NULL
TCR	NULL
enhancer	NULL
binding	NULL
proteins	NULL
are	NULL
expressed	NULL
in	NULL
both	NULL
«	NULL
B	NULL
TCR	NULL
and	NULL
y8	NULL
TCR	NULL
T	NULL
cells	NULL
.	NULL

Such	NULL
transcriptional	NULL
silencers	NULL
may	NULL
be	NULL
distinct	NULL
negative	NULL
regulatory	NULL
clements	NULL
within	NULL
these	NULL
genes	NULL
.	NULL

This	NULL
type	NULL
of	NULL
transcriptional	NULL
silencer	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
downregulate	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
a	NULL
TCR	NULL
gene	NULL
in	NULL
non-	NULL
«	NULL
fB	NULL
T	NULL
cells*	NULL
``	NULL
and	NULL
the	NULL
Immunology	NULL
Today	NULL
27	NULL
y	NULL
TCRS®	NULL
gene	NULL
in	NULL
non-y8	NULL
T	NULL
cells	NULL
$	NULL
``	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
same	NULL
multipartite	NULL
transcriptional	NULL
regulatory	NULL
element	NULL
may	NULL
function	NULL
as	NULL
both	NULL
a	NULL
silencer	NULL
and	NULL
an	NULL
enhancer	NULL
,	NULL
depending	NULL
upon	NULL
the	NULL
particular	NULL
set	NULL
of	NULL
nuclear	NULL
proteins	NULL
expressed	NULL
by	NULL
a	NULL
given	NULL
cell	NULL
type	NULL
.	NULL

Such	NULL
bifunctional	NULL
transcriptional	NULL
regulatory	NULL
elements	NULL
have	NULL
been	NULL
described	NULL
in	NULL
yeast	NULL
``	NULL
.	NULL

Moreover	NULL
,	NULL
a	NULL
recent	NULL
study	NULL
has	NULL
suggested	NULL
that	NULL
the	NULL
Ta	NULL
motif	NULL
from	NULL
the	NULL
human	NULL
«	NULL
TCR	NULL
enhancer	NULL
can	NULL
act	NULL
as	NULL
both	NULL
a	NULL
positive	NULL
and	NULL
negative	NULL
transcriptional	NULL
regulatory	NULL
element	NULL
,	NULL
depending	NULL
upon	NULL
the	NULL
precise	NULL
DNA	NULL
context	NULL
in	NULL
which	NULL
it	NULL
is	NULL
located®	NULL
``	NULL
.	NULL

Future	NULL
directions	NULL
During	NULL
the	NULL
last	NULL
few	NULL
years	NULL
,	NULL
a	NULL
great	NULL
deal	NULL
has	NULL
been	NULL
learned	NULL
about	NULL
the	NULL
molecular	NULL
mechanisms	NULL
that	NULL
regulate	NULL
«	NULL
TCR	NULL
gene	NULL
expression	NULL
during	NULL
thymocyte	NULL
development	NULL
.	NULL

These	NULL
data	NULL
are	NULL
summarized	NULL
schematically	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

The	NULL
important	NULL
cis-acting	NULL
transcriptional	NULL
activator	NULL
sequences	NULL
have	NULL
been	NULL
identified	NULL
and	NULL
characterized	NULL
,	NULL
and	NULL
a	NULL
set	NULL
of	NULL
novel	NULL
transcription	NULL
factors	NULL
,	NULL
some	NULL
of	NULL
which	NULL
are	NULL
T	NULL
cell	NULL
specific	NULL
,	NULL
have	NULL
been	NULL
cloned	NULL
.	NULL

Several	NULL
of	NULL
these	NULL
factors	NULL
,	NULL
including	NULL
the	NULL
CREB	NULL
,	NULL
TCF/LEF	NULL
,	NULL
Ets	NULL
and	NULL
GATA	NULL
proteins	NULL
,	NULL
also	NULL
appear	NULL
to	NULL
play	NULL
important	NULL
roles	NULL
in	NULL
regulating	NULL
the	NULL
expression	NULL
of	NULL
multiple	NULL
genes	NULL
during	NULL
T-cell	NULL
development	NULL
and	NULL
activation	NULL
.	NULL

Because	NULL
they	NULL
are	NULL
T	NULL
cell	NULL
specific	NULL
and	NULL
expressed	NULL
very	NULL
early	NULL
during	NULL
thymocyte	NULL
ontogeny	NULL
,	NULL
the	NULL
TCF/LEF	NULL
and	NULL
GATA-3	NULL
proteins	NULL
are	NULL
particularly	NULL
good	NULL
candidates	NULL
for	NULL
T-cell-determining	NULL
genes	NULL
.	NULL

Although	NULL
these	NULL
studies	NULL
have	NULL
addressed	NULL
a	NULL
number	NULL
of	NULL
important	NULL
questions	NULL
concerning	NULL
T-celi	NULL
development	NULL
,	NULL
they	NULL
have	NULL
raised	NULL
at	NULL
least	NULL
as	NULL
many	NULL
questions	NULL
as	NULL
they	NULL
have	NULL
answered	NULL
.	NULL

First	NULL
,	NULL
several	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
«	NULL
TCR	NULL
enhancer	NULL
have	NULL
not	NULL
yet	NULL
been	NULL
identified	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
there	NULL
is	NULL
evidence	NULL
for	NULL
a	NULL
third	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
Ta2	NULL
(	NULL
Ta	NULL
2B	NULL
,	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
(	NULL
I-C.	NULL
Ho	NULL
and	NULL
J.M	NULL
.	NULL

Leiden	NULL
,	NULL
Vol	NULL
.	NULL

13	NULL
No	NULL
.	NULL

I	NULL
1992	NULL
REVIEW	NULL
Table	NULL
2	NULL
.	NULL

Shared	NULL
nuclear	NULL
protein-binding	NULL
sites	NULL
in	NULL
multiple	NULL
transcriptional	NULL
enhancers	NULL
Transcriptional	NULL
Binding	NULL
Transcriptional	NULL
Binding	NULL
enhancer	NULL
site	NULL
enhancer	NULL
site	NULL
Ets-binding	NULL
sites	NULL
TCF-1-binding	NULL
sites	NULL
Tested	NULL
Tested	NULL
«	NULL
TCR	NULL
Enh	NULL
CAGAGGATGTG	NULL
(	NULL
Ta2	NULL
)	NULL
a	NULL
TCR	NULL
GGCACCCTTTGAA	NULL
(	NULL
Ta2	NULL
)	NULL
MSV	NULL
LTR	NULL
GAGCGGAAGCG	NULL
HIV-1	NULL
*	NULL
AGCAGTCTTTGTA	NULL
Polyoma	NULL
Enh	NULL
AGCAGGAAGTG	NULL
(	NULL
PEA3	NULL
)	NULL
Ick	NULL
GGCCTCCTGTGAA	NULL
MHC	NULL
class	NULL
II	NULL
Pr	NULL
AAGAGGAACTT	NULL
Ick	NULL
AAAAGCCTGTTTG	NULL
HTLV-1	NULL
LTR	NULL
_	NULL
GGGAGGAAATG	NULL
Ick	NULL
GAAACTCTCTGAA	NULL
IL-2	NULL
Enh	NULL
AGGAGGAAAAA	NULL
(	NULL
NF-AT-1	NULL
)	NULL
__	NULL
lek	NULL
GGATGTCTCATGT	NULL
AAGAGGAAAAA	NULL
(	NULL
IL-2B	NULL
)	NULL
CD37	NULL
TGCCTTCTCTCAA	NULL
Ig	NULL
K	NULL
3	NULL
'	NULL
Enh	NULL
TTCAGGAACTG	NULL
CD37	NULL
AGATGCCTTTITTGT	NULL
HIV-2	NULL
LTR	NULL
GACAGGAACAG	NULL
(	NULL
CD3R	NULL
)	NULL
CD36	NULL
GAAACACTTTCAA	NULL
E74	NULL
AACCGGAAGTA	NULL
CD3e	NULL
AGAGCGCTTTGTT	NULL
ATCAGGAATTA	NULL
Ig	NULL
H	NULL
Enh	NULL
GGTCCTCTTTTAA	NULL
AGTAGGAACAA	NULL
Ig	NULL
K	NULL
3	NULL
'	NULL
Enh	NULL
AAGACCCTTTGAG	NULL
TCR	NULL
B	NULL
Enh	NULL
AACAGGATGTG	NULL
(	NULL
TB3	NULL
)	NULL
B	NULL
TCR	NULL
CCTCTCCCTCTGAA	NULL
(	NULL
TBS	NULL
)	NULL
Consensus	NULL
AGG	NULL
AGG	NULL
AAATG	NULL
Consensus	NULL
C	NULL
CTCTTAA	NULL
GACC	NULL
TgAA	NULL
T-	NULL
T	NULL
GTT	NULL
Untested	NULL
Untested	NULL
GM-CSF	NULL
Pr	NULL
CAGAGGAAATG	NULL
CACAGGAACAT	NULL
ADA	NULL
AGTCTCCTTTGTT	NULL
IL-4	NULL
Pr	NULL
TCCAGGAGAAA	NULL
a	NULL
TCR	NULL
GTCCCCCTTTGAA	NULL
IL-3	NULL
Pr	NULL
CAGGAGAAA	NULL
8	NULL
TCR	NULL
AAAGCCCTTTGAA	NULL
CD2	NULL
Enh	NULL
CAGAGGAAAAA	NULL
CD3e	NULL
AGCACACTCTGCT	NULL
CD38	NULL
Enh	NULL
TTGAGGATGAG	NULL
Thy-1	NULL
GAGGTTCTGTTAC	NULL
CD3e	NULL
Enh	NULL
TGAAGGAGGGA	NULL
CD2	NULL
CTAACACTTTGGG	NULL
8	NULL
TCR	NULL
Enh	NULL
GAAAGGATTAG	NULL
CD33	NULL
AGCACCCTTACCC	NULL
GCAAGGAAACC	NULL
(	NULL
8E5	NULL
)	NULL
ACAAGGAGATA	NULL
(	NULL
8E1	NULL
)	NULL
HIV-1	NULL
LTR	NULL
CAAAGGAGAGA	NULL
HIV-2	NULL
LTR	NULL
CAGAGGAAGAG	NULL
AAGAGGAATAC	NULL
GGCAGGAAGTA	NULL
CAGAGGAATTT	NULL
GATA-binding	NULL
sites	NULL
CREs	NULL
Tested	NULL
a	NULL
TCR	NULL
Enh	NULL
TAGATAGC	NULL
(	NULL
Ta3	NULL
)	NULL
a	NULL
TCR	NULL
Enh	NULL
TGACGTCA	NULL
(	NULL
Tal	NULL
)	NULL
B	NULL
TCR	NULL
Enh	NULL
GAGATAAA	NULL
(	NULL
TB2	NULL
)	NULL
B	NULL
TCR	NULL
Enh	NULL
TCACATCA	NULL
(	NULL
TB2	NULL
)	NULL
Ig	NULL
k	NULL
3	NULL
'	NULL
Enh	NULL
AAGATAGC	NULL
V	NULL
,	NULL
TCR	NULL
Pr	NULL
TGATGTCA	NULL
8	NULL
TCR	NULL
Enh	NULL
TTGATAAC	NULL
(	NULL
8E4	NULL
)	NULL
CD38	NULL
Enh	NULL
TGACATCA	NULL
TTGATAAC	NULL
(	NULL
8E4	NULL
)	NULL
CD2	NULL
Enh	NULL
TGAGGTCA	NULL
Consensus	NULL
A	NULL
GAT	NULL
AG	NULL
Consensus	NULL
TGACGTCA	NULL
T	NULL
A	NULL
E	NULL
boxes	NULL
«	NULL
TCR	NULL
Enh	NULL
AGGCCACGTGCCGA	NULL
(	NULL
Ta3	NULL
)	NULL
B	NULL
TCR	NULL
Enh	NULL
CAGCCACCTGCCCT	NULL
Ig	NULL
k	NULL
3	NULL
'	NULL
Enh	NULL
GGCACATCTGTTGC	NULL
CD3e	NULL
Enh	NULL
GCGGCAGCTGGCGG	NULL
Consensus	NULL
CANNTG	NULL
Immunology	NULL
Today	NULL
28	NULL
Vol	NULL
.	NULL

13	NULL
No.1	NULL
1992	NULL
REVIEW	NULL
CTCCCATTTCCATGACGTCATGGTTA	NULL
Ta1	NULL
Ta2	NULL
GAGATAGCATCGCCCCAGGCCACGTGCccaaq	NULL
Ta3	NULL
Tad4	NULL
GCaACCCTTTGAAGCTCTCCCGCAGAAGCCACATCCTCTG	NULL
--	NULL
-	NULL
275	NULL
CCCCAACCGCAGGTaC	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Schematic	NULL
illustration	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
receptor	NULL
a	NULL
enhancer	NULL
and	NULL
its	NULL
cognate	NULL
nuclear	NULL
binding	NULL
proteins	NULL
.	NULL

These	NULL
proteins	NULL
are	NULL
discussed	NULL
in	NULL
detail	NULL
in	NULL
the	NULL
text	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
the	NULL
Ta2	NULL
B	NULL
protein	NULL
is	NULL
unknown	NULL
as	NULL
are	NULL
the	NULL
identities	NULL
of	NULL
the	NULL
Ta4-binding	NULL
proteins	NULL
.	NULL

unpublished	NULL
)	NULL
and	NULL
almost	NULL
nothing	NULL
is	NULL
known	NULL
about	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
Ta4-binding	NULL
proteins	NULL
.	NULL

Moreover	NULL
,	NULL
it	NULL
is	NULL
not	NULL
yet	NULL
known	NULL
which	NULL
E-box-binding	NULL
proteins	NULL
are	NULL
expressed	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Given	NULL
the	NULL
importance	NULL
of	NULL
this	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
the	NULL
bHLH	NULL
proteins	NULL
such	NULL
as	NULL
E12/E47	NULL
and	NULL
MyoD	NULL
)	NULL
in	NULL
other	NULL
developmental	NULL
this	NULL
remains	NULL
an	NULL
important	NULL
issue	NULL
.	NULL

Because	NULL
each	NULL
of	NULL
the	NULL
factors	NULL
that	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
«	NULL
TCR	NULL
enhancer	NULL
belongs	NULL
to	NULL
a	NULL
family	NULL
of	NULL
nuclear	NULL
proteins	NULL
,	NULL
it	NULL
remains	NULL
unclear	NULL
which	NULL
of	NULL
the	NULL
family	NULL
members	NULL
is	NULL
involved	NULL
in	NULL
regulating	NULL
which	NULL
gene	NULL
at	NULL
a	NULL
given	NULL
point	NULL
in	NULL
T-cell	NULL
development	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
available	NULL
evidence	NULL
suggests	NULL
that	NULL
many	NULL
of	NULL
these	NULL
factors	NULL
may	NULL
themselves	NULL
be	NULL
regulated	NULL
at	NULL
the	NULL
post-transcriptional	NULL
and	NULL
post-translational	NULL
levels	NULL
,	NULL
and	NULL
currently	NULL
,	NULL
relatively	NULL
little	NULL
about	NULL
these	NULL
processes	NULL
is	NULL
understood	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
enhancers	NULL
and	NULL
of	NULL
silencers	NULL
in	NULL
determining	NULL
lineage-specific	NULL
gene	NULL
expression	NULL
is	NULL
also	NULL
not	NULL
clear	NULL
.	NULL

Finally	NULL
,	NULL
almost	NULL
nothing	NULL
is	NULL
known	NULL
about	NULL
what	NULL
regulates	NULL
the	NULL
regulators	NULL
,	NULL
that	NULL
is	NULL
the	NULL
mechanisms	NULL
that	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
Ets-1	NULL
,	NULL
GATA-3	NULL
,	NULL
TCF-1	NULL
or	NULL
TCF-1	NULL
«	NULL
/LEF-1	NULL
during	NULL
thymocyte	NULL
differentiation	NULL
.	NULL

Over	NULL
the	NULL
next	NULL
few	NULL
years	NULL
,	NULL
gene	NULL
knock-out	NULL
experiments	NULL
,	NULL
using	NULL
homologous	NULL
recombination	NULL
along	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
trans-dominant	NULL
inhibitors	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
,	NULL
should	NULL
help	NULL
to	NULL
shed	NULL
light	NULL
on	NULL
the	NULL
function	NULL
of	NULL
the	NULL
individual	NULL
transcription	NULL
factors	NULL
.	NULL

Biochemical	NULL
studies	NULL
should	NULL
help	NULL
to	NULL
elucidate	NULL
the	NULL
post-transcriptional	NULL
and	NULL
post-translational	NULL
regulation	NULL
of	NULL
these	NULL
factors	NULL
.	NULL

Finally	NULL
,	NULL
studies	NULL
of	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
themselves	NULL
may	NULL
move	NULL
us	NULL
one	NULL
step	NULL
closer	NULL
to	NULL
identifying	NULL
the	NULL
true	NULL
master	NULL
switch	NULL
gene	NULL
(	NULL
s	NULL
)	NULL
for	NULL
the	NULL
T-cell	NULL
lineage	NULL
.	NULL

Given	NULL
the	NULL
current	NULL
level	NULL
of	NULL
interest	NULL
in	NULL
these	NULL
problems	NULL
and	NULL
the	NULL
reagents	NULL
now	NULL
available	NULL
,	NULL
further	NULL
insights	NULL
into	NULL
Immunology	NULL
Today	NULL
the	NULL
molecular	NULL
mechanisms	NULL
underlying	NULL
T-cell	NULL
determination	NULL
and	NULL
differentiation	NULL
can	NULL
be	NULL
expected	NULL
in	NULL
the	NULL
near	NULL
future	NULL
.	NULL

Jeffrey	NULL
M.	NULL
Leiden	NULL
is	NULL
at	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
and	NULL
the	NULL
Dept	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Michigan	NULL
Medical	NULL
Center	NULL
,	NULL
Ann	NULL
Arbor	NULL
,	NULL
MI	NULL
48109	NULL
,	NULL
USA	NULL
.	NULL

References	NULL
1	NULL
Metcalf	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
339	NULL
,	NULL
27-30	NULL
2	NULL
Sawyers	NULL
,	NULL
CL	NULL
.	NULL

,	NULL
Denny	NULL
,	NULL
C.T	NULL
.	NULL

and	NULL
Witte	NULL
,	NULL
O.N	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
337-3580	NULL
3	NULL
Strominger	NULL
,	NULL
J.L	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Science	NULL
244	NULL
,	NULL
943-950	NULL
4	NULL
Haynes	NULL
,	NULL
B.F.	NULL
,	NULL
Denning	NULL
,	NULL
S.M	NULL
.	NULL

,	NULL
Singer	NULL
,	NULL
K.H	NULL
.	NULL

and	NULL
Kurtzberg	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
10	NULL
,	NULL
§7-91	NULL
5	NULL
Saito	NULL
,	NULL
H.	NULL
,	NULL
Kranz	NULL
,	NULL
D.M	NULL
.	NULL

,	NULL
Takagaki	NULL
,	NULL
Y.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Nature	NULL
312	NULL
,	NULL
36-40	NULL
6	NULL
Chien	NULL
,	NULL
Y-H.	NULL
,	NULL
Becker	NULL
,	NULL
D.M	NULL
.	NULL

,	NULL
Lindsten	NULL
,	NULL
T.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Nature	NULL
312	NULL
,	NULL
31-35	NULL
7	NULL
Sim	NULL
,	NULL
G.K.	NULL
,	NULL
Yagiie	NULL
,	NULL
J.	NULL
,	NULL
Nelson	NULL
,	NULL
J.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Nature	NULL
312	NULL
,	NULL
771-775	NULL
8	NULL
Raulet	NULL
,	NULL
D.H.	NULL
,	NULL
Garman	NULL
,	NULL
R.D	NULL
.	NULL

,	NULL
Saito	NULL
,	NULL
H.	NULL
and	NULL
Tonegawa	NULL
,	NULL
S.	NULL
(	NULL
1985	NULL
)	NULL
Nature	NULL
314	NULL
,	NULL
103-107	NULL
9	NULL
Snodgrass	NULL
,	NULL
H.R	NULL
.	NULL

,	NULL
Kisielow	NULL
,	NULL
P.	NULL
,	NULL
Kiefer	NULL
,	NULL
M.	NULL
,	NULL
Steinmetz	NULL
,	NULL
M.	NULL
and	NULL
von	NULL
Boehmer	NULL
,	NULL
H.	NULL
(	NULL
1985	NULL
)	NULL
Nature	NULL
313	NULL
,	NULL
592-895	NULL
10	NULL
Chien	NULL
,	NULL
Y.	NULL
,	NULL
Iwashima	NULL
,	NULL
M.	NULL
,	NULL
Kaplan	NULL
,	NULL
K.B	NULL
.	NULL

,	NULL
Elliott	NULL
,	NULL
J.F	NULL
.	NULL

and	NULL
Davis	NULL
,	NULL
M.M	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Nature	NULL
328	NULL
,	NULL
677-682	NULL
11	NULL
Winoto	NULL
,	NULL
A.	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
338	NULL
,	NULL
430-432	NULL
12	NULL
Ho	NULL
,	NULL
[	NULL
-C.	NULL
,	NULL
Yang	NULL
,	NULL
L-H.	NULL
,	NULL
Morle	NULL
,	NULL
G.	NULL
and	NULL
Leiden	NULL
,	NULL
J.M	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
,	NULL
6714-6718	NULL
13	NULL
Winoto	NULL
,	NULL
A.	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
729-733	NULL
14	NULL
Hockett	NULL
,	NULL
R.D	NULL
.	NULL

,	NULL
de	NULL
Villartay	NULL
,	NULL
J-P.	NULL
,	NULL
Pollock	NULL
,	NULL
K.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85	NULL
,	NULL
9694-9698	NULL
209	NULL
Vol	NULL
.	NULL

13	NULL
No	NULL
.	NULL

1	NULL
1992	NULL
REVIEW	NULL
15	NULL
Ho	NULL
,	NULL
I-C.	NULL
and	NULL
Leiden	NULL
,	NULL
J.M	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
4720-4727	NULL
16	NULL
Mitchell	NULL
,	NULL
P.J	NULL
.	NULL

,	NULL
Wang	NULL
,	NULL
C.	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
50	NULL
,	NULL
847-861	NULL
17	NULL
Imagawa	NULL
,	NULL
M.	NULL
,	NULL
Chiu	NULL
,	NULL
R.	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
51	NULL
,	NULL
251-260	NULL
18	NULL
Sen	NULL
,	NULL
R.	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
46	NULL
,	NULL
705-716	NULL
19	NULL
Gottschalk	NULL
,	NULL
LR	NULL
.	NULL

and	NULL
Leiden	NULL
,	NULL
J.M	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
5486-5495	NULL
20	NULL
Gonzalez	NULL
,	NULL
G.A	NULL
.	NULL

,	NULL
Yamamoto	NULL
,	NULL
K.K	NULL
.	NULL

,	NULL
Fischer	NULL
,	NULL
W.H	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Nature	NULL
337	NULL
,	NULL
749-752	NULL
21	NULL
Hoeffler	NULL
,	NULL
J.P.	NULL
,	NULL
Meyer	NULL
,	NULL
T.E	NULL
.	NULL

,	NULL
Yun	NULL
,	NULL
Y.	NULL
,	NULL
Jameson	NULL
,	NULL
J.L	NULL
.	NULL

and	NULL
Habener	NULL
,	NULL
J.F	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Science	NULL
242	NULL
,	NULL
1430-1433	NULL
22	NULL
Maekawa	NULL
,	NULL
T.	NULL
,	NULL
Sakura	NULL
,	NULL
H.	NULL
,	NULL
Kanei-Ishii	NULL
,	NULL
C.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
2023-2028	NULL
23	NULL
Ivashkiv	NULL
,	NULL
L.B	NULL
.	NULL

,	NULL
Liou	NULL
,	NULL
H-C.	NULL
,	NULL
Kara	NULL
,	NULL
C.J	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
1609-1621	NULL
24	NULL
Hai	NULL
,	NULL
T.	NULL
,	NULL
Liu	NULL
,	NULL
F.	NULL
,	NULL
Coukos	NULL
,	NULL
W.J	NULL
.	NULL

and	NULL
Green	NULL
,	NULL
M.R	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

3	NULL
,	NULL
2083-2090	NULL
25	NULL
Liou	NULL
,	NULL
H-C.	NULL
,	NULL
Boothby	NULL
,	NULL
M.R	NULL
.	NULL

and	NULL
Glimcher	NULL
,	NULL
LH	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Science	NULL
242	NULL
,	NULL
69-71	NULL
26	NULL
Liu	NULL
,	NULL
F.	NULL
and	NULL
Green	NULL
,	NULL
M.R	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
61	NULL
,	NULL
1217-1224	NULL
27	NULL
Sheng	NULL
,	NULL
M.	NULL
,	NULL
Thompson	NULL
,	NULL
M.A	NULL
.	NULL

and	NULL
Greenberg	NULL
,	NULL
M.E	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Science	NULL
252	NULL
,	NULL
1427-1430	NULL
28	NULL
Waterman	NULL
,	NULL
M.L	NULL
.	NULL

and	NULL
Jones	NULL
,	NULL
K.A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
New	NULL
Biologist	NULL
2	NULL
,	NULL
621-636	NULL
29	NULL
Waterman	NULL
,	NULL
M.L	NULL
.	NULL

,	NULL
Fischer	NULL
,	NULL
W.H	NULL
.	NULL

and	NULL
Jones	NULL
,	NULL
K.A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
1-14	NULL
30	NULL
Travis	NULL
,	NULL
A.	NULL
,	NULL
Amsterdam	NULL
,	NULL
A.	NULL
,	NULL
Belanger	NULL
,	NULL
C.	NULL
and	NULL
Grosschedl	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
880-894	NULL
31	NULL
van	NULL
de	NULL
Wetering	NULL
,	NULL
M.	NULL
,	NULL
Oosterwegel	NULL
,	NULL
M.	NULL
,	NULL
Dooijes	NULL
,	NULL
D.	NULL
and	NULL
Clevers	NULL
,	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
123-132	NULL
32	NULL
Oosterwegel	NULL
,	NULL
M.	NULL
,	NULL
van	NULL
de	NULL
Wetering	NULL
,	NULL
M.	NULL
,	NULL
Dooijes	NULL
,	NULL
D.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

173	NULL
,	NULL
1133-1142	NULL
33	NULL
Ho	NULL
,	NULL
I-C.	NULL
,	NULL
Bhat	NULL
,	NULL
N.K	NULL
.	NULL

,	NULL
Gottschalk	NULL
,	NULL
LR	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Science	NULL
250	NULL
,	NULL
814-818	NULL
34	NULL
Gunther	NULL
,	NULL
C.V.	NULL
,	NULL
Nye	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
Bryner	NULL
,	NULL
R.S	NULL
.	NULL

and	NULL
Graves	NULL
,	NULL
B.J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
667-679	NULL
35	NULL
Klemsz	NULL
,	NULL
M.J.	NULL
,	NULL
McKercher	NULL
,	NULL
S.R	NULL
.	NULL

,	NULL
Celada	NULL
,	NULL
A.	NULL
,	NULL
Van	NULL
Beveren	NULL
,	NULL
C.	NULL
and	NULL
Maki	NULL
,	NULL
R.A.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
61	NULL
,	NULL
113-124	NULL
36	NULL
Urness	NULL
,	NULL
L.D	NULL
.	NULL

and	NULL
Thummel	NULL
,	NULL
C.S	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
63	NULL
,	NULL
47-61	NULL
37	NULL
Bosselut	NULL
,	NULL
R.	NULL
,	NULL
Duvall	NULL
,	NULL
J.F	NULL
.	NULL

,	NULL
Gégonne	NULL
,	NULL
A.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
3137-3144	NULL
38	NULL
Wasylyk	NULL
,	NULL
B.	NULL
,	NULL
Wasylyk	NULL
,	NULL
C.	NULL
,	NULL
Flores	NULL
,	NULL
P.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Nature	NULL
346	NULL
,	NULL
191-193	NULL
39	NULL
Bhat	NULL
,	NULL
N.K	NULL
.	NULL

,	NULL
Fisher	NULL
,	NULL
R.J.	NULL
,	NULL
Fujiwara	NULL
,	NULL
S.	NULL
,	NULL
Ascione	NULL
,	NULL
R.	NULL
and	NULL
Papas	NULL
,	NULL
T.S	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84	NULL
,	NULL
3161-3165	NULL
40	NULL
Bhat	NULL
,	NULL
N.K	NULL
.	NULL

,	NULL
Komschlies	NULL
,	NULL
KL	NULL
.	NULL

,	NULL
Fujiwara	NULL
,	NULL
S.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

142	NULL
,	NULL
672-678	NULL
41	NULL
Pognonec	NULL
,	NULL
P.	NULL
,	NULL
Boulukos	NULL
,	NULL
KE	NULL
.	NULL

and	NULL
Ghysdael	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Oncogene	NULL
4	NULL
,	NULL
691	NULL
-697	NULL
42	NULL
Karim	NULL
,	NULL
F.D	NULL
.	NULL

,	NULL
Urness	NULL
,	NULL
LD	NULL
.	NULL

,	NULL
Thummel	NULL
,	NULL
C.S	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1451-1453	NULL
43	NULL
Davis	NULL
,	NULL
M.	NULL
M	NULL
and	NULL
Bjorkman	NULL
,	NULL
P.J	NULL
.	NULL

(	NULL
395-401	NULL
44	NULL
Evans	NULL
,	NULL
T.	NULL
and	NULL
Felsenfeld	NULL
,	NULL
G.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
877-885	NULL
45	NULL
Tsai	NULL
,	NULL
S-F.	NULL
,	NULL
Martin	NULL
,	NULL
D.LK	NULL
.	NULL

,	NULL
Zon	NULL
,	NULL
LL	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Nature	NULL
339	NULL
,	NULL
446-451	NULL
46	NULL
Martin	NULL
,	NULL
D.LK	NULL
.	NULL

,	NULL
Zon	NULL
,	NULL
LL	NULL
.	NULL

,	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
344	NULL
,	NULL
444-447	NULL
47	NULL
Romeo	NULL
,	NULL
P-H.	NULL
,	NULL
Prandini	NULL
,	NULL
M-H.	NULL
,	NULL
Nature	NULL
344	NULL
,	NULL
447-449	NULL
48	NULL
Evans	NULL
,	NULL
T.	NULL
,	NULL
Reitman	NULL
,	NULL
M.	NULL
and	NULL
Felsenfeld	NULL
,	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
$	NULL
5	NULL
,	NULL
5976-5980	NULL
49	NULL
Pevny	NULL
,	NULL
L.	NULL
,	NULL
Simon	NULL
,	NULL
M.C	NULL
.	NULL

,	NULL
Robertson	NULL
,	NULL
E.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Nature	NULL
349	NULL
,	NULL
257-260	NULL
50	NULL
Ho	NULL
,	NULL
1-C.	NULL
,	NULL
Voorhees	NULL
,	NULL
P.	NULL
,	NULL
Marin	NULL
,	NULL
N.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
1187-1	NULL
192	NULL
51	NULL
Yamamoto	NULL
,	NULL
M.	NULL
,	NULL
Ko	NULL
,	NULL
L.J	NULL
.	NULL

,	NULL
Leonard	NULL
,	NULL
M.W	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1650-1662	NULL
52	NULL
Ko	NULL
,	NULL
L.J	NULL
.	NULL

,	NULL
Yamamoto	NULL
,	NULL
M.	NULL
,	NULL
Leonard	NULL
,	NULL
M.W	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
2778-2784	NULL
53	NULL
Redondo	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
Hata	NULL
,	NULL
S.	NULL
,	NULL
Brocklehurst	NULL
,	NULL
C.	NULL
and	NULL
Krangel	NULL
,	NULL
M.S	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Science	NULL
247	NULL
,	NULL
1225-1229	NULL
54	NULL
Lake	NULL
,	NULL
R.A.	NULL
,	NULL
Wotton	NULL
,	NULL
D.	NULL
and	NULL
Owen	NULL
,	NULL
M.J.	NULL
{	NULL
9	NULL
,	NULL
3129-3136	NULL
55	NULL
Clevers	NULL
,	NULL
H.	NULL
,	NULL
Lonberg	NULL
,	NULL
N.	NULL
,	NULL
Dunlap	NULL
,	NULL
S.	NULL
,	NULL
Lacy	NULL
,	NULL
E.	NULL
and	NULL
Terhorst	NULL
,	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
2527-2535	NULL
56	NULL
Georgopoulos	NULL
,	NULL
K.	NULL
,	NULL
van	NULL
den	NULL
Elsen	NULL
,	NULL
P.	NULL
,	NULL
Bier	NULL
,	NULL
E.	NULL
,	NULL
Maxam	NULL
,	NULL
A.	NULL
and	NULL
Terhorst	NULL
,	NULL
C.	NULL
(	NULL
1988	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

7	NULL
,	NULL
2401-2407	NULL
57	NULL
Winoto	NULL
,	NULL
A.	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
59	NULL
,	NULL
649-655	NULL
58	NULL
Ishida	NULL
,	NULL
I.	NULL
,	NULL
Verbeek	NULL
,	NULL
S.	NULL
,	NULL
Bonneville	NULL
,	NULL
M.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87	NULL
,	NULL
3067-3071	NULL
59	NULL
Brand	NULL
,	NULL
A.H.	NULL
,	NULL
Micklem	NULL
,	NULL
G.	NULL
and	NULL
Nasmyth	NULL
,	NULL
K.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
51	NULL
,	NULL
709-719	NULL
60	NULL
Ho	NULL
,	NULL
I-C.	NULL
and	NULL
Leiden	NULL
,	NULL
J.M	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172	NULL
,	NULL
1443-1449	NULL
61	NULL
Murre	NULL
,	NULL
C.	NULL
,	NULL
McCaw	NULL
,	NULL
P.S	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
56	NULL
,	NULL
777-783	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
334	NULL
,	NULL
Mutter	NULL
,	NULL
G.	NULL
and	NULL
Orkin	NULL
,	NULL
S.H	NULL
.	NULL

Joulin	NULL
,	NULL
V.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
(	NULL
1990	NULL
)	NULL
EMBO	NULL
J.	NULL
gar	NULL
?	NULL

Tel	NULL
+36-1-1222-203	NULL
Fax	NULL
+36-1-1424-118	NULL
The	NULL
Budapest	NULL
Bulletin	NULL
:	NULL
Congress	NULL
:	NULL
ews	NULL
Number	NULL
1	NULL
5-168	NULL
mama	NULL
,	NULL
Dozsa	NULL
Gyorgy	NULL
ut	NULL
84/a	NULL
,	NULL
Immunology	NULL
Today	NULL
3	NULL
)	NULL
Vol	NULL
.	NULL

13	NULL
No	NULL
.	NULL

1	NULL
1992	NULL

